##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_17,Status=affected,Gender=n/a>
##DESCRIPTION=genotype=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, ExAC pLI score).
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=off-target=Variant outside the panel/exome target region.
##FILTER=pred_pathogenic=Variant predicted to be pathogenic by one or more tools (conservation or effect prediction).
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	Kaviar	phyloP	Sift	MetaLR	PolyPhen2	FATHMM	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr4	90636807	90636807	-	AC	hom		QUAL=2125;DP=162;AF=0.63;MQM=60	GPRIN3-SNCA	intergenic_region	GPRIN3-SNCA:GPRIN3-SNCA:intergenic_region:MODIFIER::n.90636807_90636808insAC:		rs779592265	0.0000	0.0000	0/0/0	0.0803											0	3					GPRIN3-SNCA (inh=n/a pLI=n/a)
chr4	90646687	90646687	T	-	het		QUAL=1110;DP=346;AF=0.21;MQM=60	SNCA	3'UTR	SNCA:NM_000345.3:3'UTR:MODIFIER:exon6/6:c.*1092delA:,SNCA:NM_001146054.1:3'UTR:MODIFIER:exon6/6:c.*1092delA:,SNCA:NM_007308.2:3'UTR:MODIFIER:exon5/5:c.*1092delA:,SNCA:NM_001146055.1:3'UTR:MODIFIER:exon6/6:c.*1092delA:	MER103C	rs571454522	0.0000	0.0000	0/0/0	0.0027							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	45					SNCA (inh=AD pLI=0.84)
chr4	90655798	90655798	C	T	het		QUAL=4507;DP=342;AF=0.50;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-5370G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-5370G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-7987G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-5370G>A:		rs12505201	0.0044	0.0000	0/0/0	0.0077							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90662941	90662941	A	-	het		QUAL=999;DP=335;AF=0.21;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-12513delT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-12513delT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-15130delT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-12513delT:	AluSc	rs397878380;rs568597892	0.0000	0.0000	0/0/0	0.1289							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				1	580					SNCA (inh=AD pLI=0.84)
chr4	90670430	90670430	T	-	het		QUAL=513;DP=223;AF=0.21;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-20002delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-20002delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-22619delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-20002delA:	AluSq2	rs545509976	0.0000	0.0000	0/0/0	0.0010							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	36					SNCA (inh=AD pLI=0.84)
chr4	90671390	90671390	T	-	het		QUAL=338;DP=127;AF=0.24;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-20962delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-20962delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-23579delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-20962delA:	AluSz	rs574145495;rs60811651	0.3896	0.0000	0/0/0	0.0991							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				3	376					SNCA (inh=AD pLI=0.84)
chr4	90676930	90676930	T	-	het		QUAL=250;DP=63;AF=0.24;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-26502delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-26502delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-29119delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-26502delA:	AluSp		0.0000	0.0000	0/0/0	0.0002							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	2					SNCA (inh=AD pLI=0.84)
chr4	90680450	90680450	A	-	het		QUAL=358;DP=270;AF=0.19;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-30022delT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-30022delT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-32639delT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-30022delT:			0.0000	0.0000	0/0/0	0.0013							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	7					SNCA (inh=AD pLI=0.84)
chr4	90680974	90680974	T	-	het		QUAL=383;DP=205;AF=0.20;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-30546delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-30546delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-33163delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-30546delA:	(T)n	rs578215559	0.0000	0.0000	0/0/0	0.0129							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				1	77					SNCA (inh=AD pLI=0.84)
chr4	90685583	90685583	T	-	het		QUAL=354;DP=289;AF=0.20;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-35155delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-35155delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-37772delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-35155delA:	AluSc8	rs11347916;rs869140128	0.7650	0.0000	0/0/0	0.3871							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				1	530					SNCA (inh=AD pLI=0.84)
chr4	90693820	90693820	T	-	het		QUAL=62;DP=81;AF=0.16;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.307-43392delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.307-43392delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.307-46009delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.307-43392delA:	AluSx3	rs11329703;rs397881001;rs763962022	0.5036	0.0000	0/0/0	0.4095							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				102	340					SNCA (inh=AD pLI=0.84)
chr4	90700352	90700352	A	-	het		QUAL=421;DP=387;AF=0.17;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+43045delT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+43045delT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+43045delT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+43045delT:	L1PB1	rs563700689	0.0000	0.0000	0/0/0	0.0072							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	38					SNCA (inh=AD pLI=0.84)
chr4	90704617	90704617	G	A	hom		QUAL=8053;DP=268;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+38780C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+38780C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+38780C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+38780C>T:		rs356185	0.1086	0.0000	0/0/0	0.1927							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90705364	90705364	A	G	hom		QUAL=12530;DP=379;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+38033T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+38033T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+38033T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+38033T>C:		rs356186	0.7947	0.0000	0/0/0	0.8005							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				319	226					SNCA (inh=AD pLI=0.84)
chr4	90707771	90707771	-	AAA	hom		QUAL=481;DP=86;AF=0.24;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+35623_306+35625dupTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+35623_306+35625dupTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+35623_306+35625dupTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+35623_306+35625dupTTT:	Alu	rs10659555;rs10684814;rs386400780	0.0000	0.0000	0/0/0	0.0021							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	1					SNCA (inh=AD pLI=0.84)
chr4	90707947	90707947	T	C	hom		QUAL=6632;DP=209;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+35450A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+35450A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+35450A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+35450A>G:		rs2737033	0.1358	0.0000	0/0/0	0.2037							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90709169	90709169	G	A	hom		QUAL=14161;DP=427;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+34228C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+34228C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+34228C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+34228C>T:	L1MC4	rs2737032	0.8948	0.0000	0/0/0	0.7935							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				431	146					SNCA (inh=AD pLI=0.84)
chr4	90709231	90709232	GA	-	het		QUAL=3857;DP=346;AF=0.51;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+34165_306+34166delTC:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+34165_306+34166delTC:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+34165_306+34166delTC:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+34165_306+34166delTC:	(TG)n	rs796264213;rs797022464	0.0000	0.0000	0/0/0	0.3482							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	42					SNCA (inh=AD pLI=0.84)
chr4	90709234	90709234	A	T	het		QUAL=2542;DP=336;AF=0.38;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+34163T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+34163T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+34163T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+34163T>A:	(TG)n	rs2737031	0.1783	0.0000	0/0/0	0.0376							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				32	318					SNCA (inh=AD pLI=0.84)
chr4	90710099	90710099	C	T	hom		QUAL=12133;DP=367;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+33298G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+33298G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+33298G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+33298G>A:		rs2737030	0.7794	0.0000	0/0/0	0.7895							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	234					SNCA (inh=AD pLI=0.84)
chr4	90711770	90711770	T	C	hom		QUAL=11781;DP=370;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+31627A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+31627A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+31627A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+31627A>G:		rs2737029	0.5068	0.0000	0/0/0	0.4541							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				180	265					SNCA (inh=AD pLI=0.84)
chr4	90711812	90711812	G	C	het		QUAL=5623;DP=469;AF=0.45;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+31585C>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+31585C>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+31585C>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+31585C>G:		rs72657744	0.0000	0.0000	0/0/0	0.0001							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90712156	90712156	-	TT	het		QUAL=460;DP=168;AF=0.29;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+31239_306+31240dupAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+31239_306+31240dupAA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+31239_306+31240dupAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+31239_306+31240dupAA:		rs371500445;rs754970214	0.0000	0.0000	0/0/0	0.2666							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	2					SNCA (inh=AD pLI=0.84)
chr4	90712205	90712205	C	A	hom		QUAL=7676;DP=278;AF=0.99;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+31192G>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+31192G>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+31192G>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+31192G>T:	THE1D	rs2572320	0.8029	0.0000	0/0/0	0.7178							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				317	226					SNCA (inh=AD pLI=0.84)
chr4	90712515	90712515	-	T	het		QUAL=4134;DP=291;AF=0.63;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+30881dupA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+30881dupA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+30881dupA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+30881dupA:		rs397879351	0.7328	0.0000	0/0/0	0.4878							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	520					SNCA (inh=AD pLI=0.84)
chr4	90712556	90712556	-	T	hom		QUAL=7146;DP=283;AF=0.90;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+30840dupA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+30840dupA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+30840dupA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+30840dupA:	L1PA2	rs140695649	0.2606	0.0000	0/0/0	0.1717							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				8	200					SNCA (inh=AD pLI=0.84)
chr4	90713443	90713454	TTGTTGTTGTTG	-	hom		QUAL=6249;DP=266;AF=0.89;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+29943_306+29954delCAACAACAACAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+29943_306+29954delCAACAACAACAA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+29943_306+29954delCAACAACAACAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+29943_306+29954delCAACAACAACAA:	(TTG)n	rs397994465;rs70963042;rs752456349	0.0000	0.0000	0/0/0	0.2808							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				47	57					SNCA (inh=AD pLI=0.84)
chr4	90713747	90713747	T	C	hom		QUAL=3433;DP=110;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+29650A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+29650A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+29650A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+29650A>G:	AluSc5	rs2583962	0.7794	0.0000	0/0/0	0.7139							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	233					SNCA (inh=AD pLI=0.84)
chr4	90717016	90717016	A	G	hom		QUAL=17334;DP=527;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+26381T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+26381T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+26381T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+26381T>C:		rs2737028	0.7794	0.0000	0/0/0	0.7890							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90717426	90717427	AA	-	hom		QUAL=549;DP=36;AF=0.67;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+25970_306+25971delTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+25970_306+25971delTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+25970_306+25971delTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+25970_306+25971delTT:	AluSx1	rs66941164;rs869146247	0.5365	0.0000	0/0/0	0.3109							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				42	226					SNCA (inh=AD pLI=0.84)
chr4	90718390	90718390	G	C	het		QUAL=6370;DP=475;AF=0.51;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+25007C>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+25007C>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+25007C>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+25007C>G:	LTR16B1	rs33978842	0.0166	0.0000	0/0/0	0.0273							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	14					SNCA (inh=AD pLI=0.84)
chr4	90718719	90718719	C	T	hom		QUAL=10748;DP=331;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+24678G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+24678G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+24678G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+24678G>A:	L1ME1	rs2572318	0.7792	0.0000	0/0/0	0.7151							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	234					SNCA (inh=AD pLI=0.84)
chr4	90719192	90719192	A	G	hom		QUAL=9135;DP=275;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+24205T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+24205T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+24205T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+24205T>C:		rs2737025	0.7792	0.0000	0/0/0	0.7850							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				309	232					SNCA (inh=AD pLI=0.84)
chr4	90720365	90720365	T	C	hom		QUAL=11207;DP=347;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+23032A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+23032A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+23032A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+23032A>G:		rs2583958	0.1080	0.0000	0/0/0	0.1923							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90721560	90721560	A	G	hom		QUAL=6649;DP=202;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+21837T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+21837T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+21837T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+21837T>C:		rs2737024	0.1078	0.0000	0/0/0	0.1929							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90721637	90721637	C	G	hom		QUAL=5749;DP=181;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+21760G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+21760G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+21760G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+21760G>C:		rs2583959	0.1080	0.0000	0/0/0	0.1928							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90722433	90722433	G	A	hom		QUAL=15305;DP=464;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+20964C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+20964C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+20964C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+20964C>T:	LTR33	rs2619373	0.1080	0.0000	0/0/0	0.1927							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90723576	90723576	T	-	het		QUAL=463;DP=120;AF=0.27;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+19821delA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+19821delA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+19821delA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+19821delA:	AluSz6	rs11304435;rs35047774;rs778275739	0.0000	0.0000	0/0/0	0.1863							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	417					SNCA (inh=AD pLI=0.84)
chr4	90723733	90723736	TCTG	-	hom		QUAL=1883;DP=75;AF=0.96;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+19661_306+19664delCAGA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+19661_306+19664delCAGA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+19661_306+19664delCAGA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+19661_306+19664delCAGA:	AluSz6	rs71862819	0.1082	0.0000	0/0/0	0.1563							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				5	78					SNCA (inh=AD pLI=0.84)
chr4	90723867	90723870	TTTT	-	hom		QUAL=711;DP=32;AF=0.97;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+19527_306+19530delAAAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+19527_306+19530delAAAA:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+19527_306+19530delAAAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+19527_306+19530delAAAA:	(TCTT)n	rs111750145	0.0000	0.0000	0/0/0	0.4599							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				98	272					SNCA (inh=AD pLI=0.84)
chr4	90724869	90724869	G	A	hom		QUAL=8540;DP=269;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+18528C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+18528C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+18528C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+18528C>T:	THE1D	rs2583960	0.6104	0.0000	0/0/0	0.6776							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				102	288					SNCA (inh=AD pLI=0.84)
chr4	90726504	90726504	-	AAA	het		QUAL=1797;DP=123;AF=0.49;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+16890_306+16892dupTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+16890_306+16892dupTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+16890_306+16892dupTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+16890_306+16892dupTTT:		rs3836644;rs71594896	0.0000	0.0000	0/0/0	0.0848							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	7					SNCA (inh=AD pLI=0.84)
chr4	90726504	90726504	-	AA	het		QUAL=1797;DP=123;AF=0.18;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+16891_306+16892dupTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+16891_306+16892dupTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+16891_306+16892dupTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+16891_306+16892dupTT:		rs71594896	0.0000	0.0000	0/0/0	0.0181							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	8					SNCA (inh=AD pLI=0.84)
chr4	90727088	90727088	C	T	hom		QUAL=9730;DP=294;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+16309G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+16309G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+16309G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+16309G>A:		rs2583963	0.7788	0.0000	0/0/0	0.7528							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	233					SNCA (inh=AD pLI=0.84)
chr4	90727218	90727218	A	G	hom		QUAL=5647;DP=176;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+16179T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+16179T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+16179T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+16179T>C:	AluJo	rs2583964	0.7792	0.0000	0/0/0	0.6880							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90729602	90729602	A	G	hom		QUAL=14563;DP=446;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+13795T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+13795T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+13795T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+13795T>C:		rs2197120	0.7792	0.0000	0/0/0	0.7893							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90729747	90729747	T	G	hom		QUAL=18977;DP=581;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+13650A>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+13650A>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+13650A>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+13650A>C:	L2	rs2619368	0.7792	0.0000	0/0/0	0.7890							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	234					SNCA (inh=AD pLI=0.84)
chr4	90730647	90730648	AC	-	hom		QUAL=675;DP=100;AF=0.30;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+12749_306+12750delGT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+12749_306+12750delGT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+12749_306+12750delGT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+12749_306+12750delGT:	(AC)n	rs72025239	0.0000	0.0000	0/0/0	0.0923							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	1					SNCA (inh=AD pLI=0.84)
chr4	90734961	90734961	G	A	hom		QUAL=9947;DP=309;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+8436C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+8436C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+8436C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+8436C>T:		rs748849	0.7792	0.0000	0/0/0	0.7874							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	233					SNCA (inh=AD pLI=0.84)
chr4	90736006	90736006	A	C	hom		QUAL=8815;DP=265;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+7391T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+7391T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+7391T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+7391T>G:		rs1837890	0.6104	0.0000	0/0/0	0.6772							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	286					SNCA (inh=AD pLI=0.84)
chr4	90736024	90736024	A	T	hom		QUAL=8112;DP=250;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+7373T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+7373T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+7373T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+7373T>A:		rs1442143	0.6124	0.0000	0/0/0	0.6769							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	286					SNCA (inh=AD pLI=0.84)
chr4	90736113	90736113	T	C	hom		QUAL=7238;DP=222;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+7284A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+7284A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+7284A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+7284A>G:		rs1442144	0.7794	0.0000	0/0/0	0.7636							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	232					SNCA (inh=AD pLI=0.84)
chr4	90736131	90736131	C	G	hom		QUAL=7888;DP=245;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+7266G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+7266G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+7266G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+7266G>C:		rs1837891	0.7788	0.0000	0/0/0	0.7636							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	232					SNCA (inh=AD pLI=0.84)
chr4	90736585	90736585	C	T	hom		QUAL=2279;DP=72;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+6812G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+6812G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+6812G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+6812G>A:		rs2619370	0.1096	0.0000	0/0/0	0.1940							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90736678	90736678	A	G	hom		QUAL=2357;DP=75;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+6719T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+6719T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+6719T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+6719T>C:		rs2619371	0.1082	0.0000	0/0/0	0.1928							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90736727	90736727	A	G	hom		QUAL=2408;DP=78;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+6670T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+6670T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+6670T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+6670T>C:		rs2619372	0.6102	0.0000	0/0/0	0.6747							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	285					SNCA (inh=AD pLI=0.84)
chr4	90736923	90736923	G	A	hom		QUAL=5272;DP=166;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+6474C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+6474C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+6474C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+6474C>T:		rs1442145	0.6120	0.0000	0/0/0	0.6721							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	288					SNCA (inh=AD pLI=0.84)
chr4	90739255	90739255	A	G	hom		QUAL=5383;DP=164;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+4142T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+4142T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+4142T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+4142T>C:		rs972880	0.6122	0.0000	0/0/0	0.6766							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	288					SNCA (inh=AD pLI=0.84)
chr4	90739505	90739505	T	C	hom		QUAL=7934;DP=244;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+3892A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+3892A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+3892A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+3892A>G:		rs2737023	0.1082	0.0000	0/0/0	0.1932							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90739662	90739662	A	C	hom		QUAL=10090;DP=313;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+3735T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+3735T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+3735T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+3735T>G:		rs2737022	0.1082	0.0000	0/0/0	0.1929							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90739992	90739992	T	A	hom		QUAL=7227;DP=218;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+3405A>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+3405A>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+3405A>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+3405A>T:		rs2737021	0.7792	0.0000	0/0/0	0.7891							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90740103	90740103	G	T	hom		QUAL=5323;DP=168;AF=0.98;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+3294C>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+3294C>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+3294C>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+3294C>A:		rs2583965	0.1082	0.0000	0/0/0	0.1924							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90740878	90740878	G	A	hom		QUAL=6573;DP=205;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+2519C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+2519C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+2519C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+2519C>T:	MIR3	rs2737020	0.6122	0.0000	0/0/0	0.6771							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				104	287					SNCA (inh=AD pLI=0.84)
chr4	90741519	90741519	G	A	hom		QUAL=9366;DP=288;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+1878C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+1878C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+1878C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+1878C>T:	Charlie4z	rs2583966	0.1082	0.0000	0/0/0	0.1931							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90741773	90741773	A	G	hom		QUAL=8332;DP=253;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+1624T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+1624T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+1624T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+1624T>C:		rs2619341	0.7786	0.0000	0/0/0	0.7889							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90742418	90742418	G	A	het		QUAL=37;DP=231;AF=0.16;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+979C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+979C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+979C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+979C>T:	A-rich	rs75234410	0.0018	0.0000	0/0/0	0.0298							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	77					SNCA (inh=AD pLI=0.84)
chr4	90742450	90742450	-	GAAAAGAAAGAAAAGGAAAGAAGGAAGGAAGGAAGCAAGAAAGAAAAAAGAGAAAGAAAGA	het		QUAL=383;DP=96;AF=0.43;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+946_306+947insTCTTTCTTTCTCTTTTTTCTTTCTTGCTTCCTTCCTTCCTTCTTTCCTTTTCTTTCTTTTC:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+946_306+947insTCTTTCTTTCTCTTTTTTCTTTCTTGCTTCCTTCCTTCCTTCTTTCCTTTTCTTTCTTTTC:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+946_306+947insTCTTTCTTTCTCTTTTTTCTTTCTTGCTTCCTTCCTTCCTTCTTTCCTTTTCTTTCTTTTC:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+946_306+947insTCTTTCTTTCTCTTTTTTCTTTCTTGCTTCCTTCCTTCCTTCTTTCCTTTTCTTTCTTTTC:	A-rich		0.0000	0.0000	0/0/0	0.0000							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90742455	90742455	-	AAA	het		QUAL=484;DP=87;AF=0.33;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+941_306+942insTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+941_306+942insTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+941_306+942insTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+941_306+942insTTT:	A-rich	rs374740558	0.0000	0.0000	0/0/0	0.0204							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	58					SNCA (inh=AD pLI=0.84)
chr4	90742457	90742457	G	A	het		QUAL=242;DP=46;AF=0.35;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+940C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+940C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+940C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+940C>T:	A-rich	rs377513610	0.0000	0.0000	0/0/0	0.0001							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	9					SNCA (inh=AD pLI=0.84)
chr4	90742458	90742458	A	G	het		QUAL=242;DP=46;AF=0.35;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+939T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+939T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+939T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+939T>C:	A-rich	rs369439490	0.0000	0.0000	0/0/0	0.0001							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	9					SNCA (inh=AD pLI=0.84)
chr4	90742462	90742462	G	A	het		QUAL=575;DP=92;AF=0.32;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+935C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+935C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+935C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+935C>T:	A-rich	rs62306328	0.0000	0.0000	0/0/0	0.0873							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				55	386					SNCA (inh=AD pLI=0.84)
chr4	90742469	90742469	G	A	het		QUAL=695;DP=86;AF=0.33;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+928C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+928C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+928C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+928C>T:	A-rich	rs13128806	0.5008	0.0000	0/0/0	0.1829							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				33	409					SNCA (inh=AD pLI=0.84)
chr4	90742473	90742473	G	-	het		QUAL=695;DP=86;AF=0.33;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+924delC:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+924delC:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+924delC:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+924delC:	A-rich	rs373813454	0.5008	0.0000	0/0/0	0.1398							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				33	406					SNCA (inh=AD pLI=0.84)
chr4	90742474	90742474	G	A	het		QUAL=695;DP=86;AF=0.33;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+923C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+923C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+923C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+923C>T:	A-rich	rs373754794	0.5008	0.0000	0/0/0	0.0957							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				33	406					SNCA (inh=AD pLI=0.84)
chr4	90742476	90742476	A	T	het		QUAL=695;DP=86;AF=0.33;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+921T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+921T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+921T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+921T>A:	A-rich	rs377538573	0.5008	0.0000	0/0/0	0.0956							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				33	406					SNCA (inh=AD pLI=0.84)
chr4	90742489	90742489	-	AAAGAAAGTAAAGAAAGAAAGA	het		QUAL=2913;DP=127;AF=0.43;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+907_306+908insTCTTTCTTTCTTTACTTTCTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+907_306+908insTCTTTCTTTCTTTACTTTCTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+907_306+908insTCTTTCTTTCTTTACTTTCTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+907_306+908insTCTTTCTTTCTTTACTTTCTTT:	A-rich	rs796970570	0.0000	0.0000	0/0/0	0.0363							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	31					SNCA (inh=AD pLI=0.84)
chr4	90742489	90742489	G	A	het		QUAL=2913;DP=127;AF=0.55;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+908C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+908C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+908C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+908C>T:	A-rich	rs79624097	0.0000	0.0000	0/0/0	0.0378							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				1	134					SNCA (inh=AD pLI=0.84)
chr4	90742713	90742715	GTA	-	hom		QUAL=6952;DP=256;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon4/5:c.306+682_306+684delTAC:,SNCA:NM_001146054.1:intron:MODIFIER:exon4/5:c.306+682_306+684delTAC:,SNCA:NM_007308.2:intron:MODIFIER:exon4/4:c.306+682_306+684delTAC:,SNCA:NM_001146055.1:intron:MODIFIER:exon4/5:c.306+682_306+684delTAC:		rs869248588	0.1080	0.0000	0/0/0	0.1921							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90744100	90744100	C	T	hom		QUAL=1657;DP=54;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-561G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-561G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-561G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-561G>A:	AluSq2	rs2583967	0.1086	0.0000	0/0/0	0.1930							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90744170	90744170	A	T	hom		QUAL=1356;DP=45;AF=0.98;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-631T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-631T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-631T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-631T>A:	AluSq2	rs2619342	0.1080	0.0000	0/0/0	0.1803							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	84					SNCA (inh=AD pLI=0.84)
chr4	90744221	90744221	C	T	hom		QUAL=1624;DP=53;AF=0.98;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-682G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-682G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-682G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-682G>A:	AluSq2	rs2619343	0.1082	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90744248	90744248	C	T	hom		QUAL=1771;DP=54;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-709G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-709G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-709G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-709G>A:	AluSq2	rs2619344	0.1156	0.0000	0/0/0	0.2004							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90744270	90744270	A	G	hom		QUAL=2024;DP=62;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-731T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-731T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-731T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-731T>C:	AluSq2	rs2619345	0.1082	0.0000	0/0/0	0.1909							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90744721	90744721	G	AAA	hom		QUAL=6989;DP=291;AF=0.75;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1182delCinsTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1182delCinsTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1182delCinsTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1182delCinsTTT:	L1MA6		0.0000	0.0000	0/0/0	0.0292							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90744903	90744903	G	T	hom		QUAL=3441;DP=105;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1364C>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1364C>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1364C>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1364C>A:		rs2737019	0.1080	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90744937	90744937	-	TTATTTATTTAT	het		QUAL=1482;DP=66;AF=0.32;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1410_164-1399dupATAAATAAATAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1410_164-1399dupATAAATAAATAA:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1410_164-1399dupATAAATAAATAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1410_164-1399dupATAAATAAATAA:	(TATT)n	rs71594899	0.0000	0.0000	0/0/0	0.0000							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				1	5					SNCA (inh=AD pLI=0.84)
chr4	90744937	90744937	-	TTATTTAT	het		QUAL=1482;DP=66;AF=0.32;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1406_164-1399dupATAAATAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1406_164-1399dupATAAATAA:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1406_164-1399dupATAAATAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1406_164-1399dupATAAATAA:	(TATT)n	rs70963044;rs71594899	0.0000	0.0000	0/0/0	0.0260							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	49					SNCA (inh=AD pLI=0.84)
chr4	90744993	90744993	-	TGGA	hom		QUAL=1304;DP=44;AF=0.95;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1458_164-1455dupTCCA:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1458_164-1455dupTCCA:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1458_164-1455dupTCCA:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1458_164-1455dupTCCA:	AluYj4	rs202067670;rs35602429	0.1076	0.0000	0/0/0	0.1051							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				3	79					SNCA (inh=AD pLI=0.84)
chr4	90745091	90745091	T	C	hom		QUAL=862;DP=32;AF=0.94;MQM=58	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1552A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1552A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1552A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1552A>G:	AluYj4	rs2737018	0.1070	0.0000	0/0/0	0.0842							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745104	90745104	A	G	hom		QUAL=983;DP=36;AF=0.97;MQM=57	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1565T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1565T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1565T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1565T>C:	AluYj4	rs2619346	0.1070	0.0000	0/0/0	0.0953							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	84					SNCA (inh=AD pLI=0.84)
chr4	90745238	90745238	C	T	hom		QUAL=1982;DP=65;AF=1.00;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1699G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1699G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1699G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1699G>A:	AluYj4	rs2737017	0.1074	0.0000	0/0/0	0.1740							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745242	90745242	T	C	hom		QUAL=1982;DP=65;AF=1.00;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1703A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1703A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1703A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1703A>G:	AluYj4	rs2737016	0.1074	0.0000	0/0/0	0.1744							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745283	90745283	T	C	hom		QUAL=3051;DP=97;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1744A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1744A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1744A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1744A>G:		rs2737015	0.1074	0.0000	0/0/0	0.1896							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745345	90745345	A	T	hom		QUAL=6528;DP=200;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1806T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1806T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1806T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1806T>A:		rs3113355	0.7778	0.0000	0/0/0	0.7868							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	233					SNCA (inh=AD pLI=0.84)
chr4	90745395	90745395	C	G	hom		QUAL=9153;DP=281;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1856G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1856G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1856G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1856G>C:		rs2583968	0.7748	0.0000	0/0/0	0.7851							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	233					SNCA (inh=AD pLI=0.84)
chr4	90745456	90745456	A	C	hom		QUAL=10661;DP=326;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1917T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1917T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1917T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1917T>G:		rs2737014	0.1084	0.0000	0/0/0	0.1903							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745503	90745503	C	T	hom		QUAL=6633;DP=207;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-1964G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-1964G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-1964G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-1964G>A:		rs2737013	0.1074	0.0000	0/0/0	0.1894							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745707	90745707	G	A	hom		QUAL=3609;DP=112;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-2168C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-2168C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-2168C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-2168C>T:		rs2737012	0.1074	0.0000	0/0/0	0.1894							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90745770	90745770	G	A	hom		QUAL=2885;DP=102;AF=0.98;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-2231C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-2231C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-2231C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-2231C>T:		rs2619347	0.7774	0.0000	0/0/0	0.7390							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				308	232					SNCA (inh=AD pLI=0.84)
chr4	90746133	90746133	T	C	hom		QUAL=11178;DP=337;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-2594A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-2594A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-2594A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-2594A>G:		rs2583969	0.1074	0.0000	0/0/0	0.1676							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90746219	90746219	T	C	hom		QUAL=5801;DP=183;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-2680A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-2680A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-2680A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-2680A>G:		rs2737011	0.7937	0.0000	0/0/0	0.6429							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				317	226					SNCA (inh=AD pLI=0.84)
chr4	90746321	90746321	C	G	hom		QUAL=3706;DP=113;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.164-2782G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.164-2782G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.164-2782G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.164-2782G>C:		rs2619348	0.1074	0.0000	0/0/0	0.1474							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90746466	90746466	G	A	hom		QUAL=1412;DP=42;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2828C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2828C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2828C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2828C>T:		rs2737010	0.7865	0.0000	0/0/0	0.6386							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				303	232					SNCA (inh=AD pLI=0.84)
chr4	90746610	90746610	G	A	hom		QUAL=1750;DP=58;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2684C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2684C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2684C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2684C>T:		rs2583970	0.1074	0.0000	0/0/0	0.1637							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90746626	90746626	-	G	hom		QUAL=2098;DP=77;AF=0.97;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2667dupC:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2667dupC:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2667dupC:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2667dupC:		rs397749345	0.1074	0.0000	0/0/0	0.1557							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90746646	90746646	G	T	hom		QUAL=2499;DP=80;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2648C>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2648C>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2648C>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2648C>A:		rs2619349	0.7776	0.0000	0/0/0	0.6790							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90746836	90746836	A	G	hom		QUAL=12992;DP=422;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2458T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2458T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2458T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2458T>C:		rs2737009	0.1074	0.0000	0/0/0	0.1859							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90746879	90746879	A	-	hom		QUAL=9976;DP=403;AF=0.88;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2415delT:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2415delT:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2415delT:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2415delT:		rs36056834;rs397880489	0.1084	0.0000	0/0/0	0.1157							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				5	87					SNCA (inh=AD pLI=0.84)
chr4	90747004	90747004	A	G	hom		QUAL=7016;DP=215;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2290T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2290T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2290T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2290T>C:		rs2619350	0.1074	0.0000	0/0/0	0.1912							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90747183	90747183	G	A	hom		QUAL=7149;DP=221;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2111C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2111C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2111C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2111C>T:		rs2737008	0.1074	0.0000	0/0/0	0.1901							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90747207	90747207	C	T	hom		QUAL=9258;DP=277;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+2087G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+2087G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+2087G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+2087G>A:		rs2583971	0.1074	0.0000	0/0/0	0.1899							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90747411	90747411	T	G	hom		QUAL=11700;DP=354;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1883A>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1883A>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1883A>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1883A>C:	MER103C	rs2583972	0.7720	0.0000	0/0/0	0.7541							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	233					SNCA (inh=AD pLI=0.84)
chr4	90747499	90747499	C	T	hom		QUAL=7679;DP=234;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1795G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1795G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1795G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1795G>A:	MER103C	rs2583973	0.1076	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90747636	90747636	A	T	hom		QUAL=3153;DP=142;AF=0.81;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1658T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1658T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1658T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1658T>A:	(CA)n	rs368025377	0.1030	0.0000	0/0/0	0.0196							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	83					SNCA (inh=AD pLI=0.84)
chr4	90747638	90747638	A	T	hom		QUAL=2163;DP=111;AF=0.28;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1656T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1656T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1656T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1656T>A:	(CA)n	rs371726760	0.1046	0.0000	0/0/0	0.0199							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	70					SNCA (inh=AD pLI=0.84)
chr4	90747640	90747640	A	T	hom		QUAL=2163;DP=111;AF=0.28;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1654T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1654T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1654T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1654T>A:	(CA)n	rs376391910	0.1044	0.0000	0/0/0	0.0268							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	68					SNCA (inh=AD pLI=0.84)
chr4	90747642	90747642	A	T	hom		QUAL=2163;DP=111;AF=0.28;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1652T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1652T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1652T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1652T>A:	(CA)n	rs369662496	0.0000	0.0000	0/0/0	0.0056							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	66					SNCA (inh=AD pLI=0.84)
chr4	90747644	90747644	G	T	het		QUAL=2163;DP=111;AF=0.62;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1650C>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1650C>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1650C>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1650C>A:	(CA)n	rs368974831	0.0000	0.0000	0/0/0	0.0001							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				2	35					SNCA (inh=AD pLI=0.84)
chr4	90747644	90747644	G	A	het		QUAL=2163;DP=111;AF=0.28;MQM=59	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1650C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1650C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1650C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1650C>T:	(CA)n	rs368974831	0.0000	0.0000	0/0/0	0.0007							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	18					SNCA (inh=AD pLI=0.84)
chr4	90747704	90747704	A	G	hom		QUAL=4555;DP=147;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1590T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1590T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1590T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1590T>C:		rs2619351	0.1074	0.0000	0/0/0	0.1883							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	84					SNCA (inh=AD pLI=0.84)
chr4	90747709	90747709	C	T	hom		QUAL=4664;DP=149;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1585G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1585G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1585G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1585G>A:		rs2619352	0.1074	0.0000	0/0/0	0.1875							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	84					SNCA (inh=AD pLI=0.84)
chr4	90747751	90747751	C	T	hom		QUAL=4490;DP=143;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1543G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1543G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1543G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1543G>A:		rs1811442	0.7776	0.0000	0/0/0	0.7869							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	233					SNCA (inh=AD pLI=0.84)
chr4	90747883	90747883	G	C	hom		QUAL=2192;DP=69;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1411C>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1411C>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1411C>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1411C>G:		rs1811443	0.7750	0.0000	0/0/0	0.7862							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				305	235					SNCA (inh=AD pLI=0.84)
chr4	90747975	90747975	G	C	hom		QUAL=2984;DP=96;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1319C>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1319C>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1319C>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1319C>G:		rs2619353	0.1074	0.0000	0/0/0	0.1915							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90748284	90748284	C	T	hom		QUAL=10010;DP=307;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+1010G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+1010G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+1010G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+1010G>A:	MIR	rs2619354	0.1076	0.0000	0/0/0	0.1907							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90748297	90748297	T	C	hom		QUAL=10264;DP=322;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+997A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+997A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+997A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+997A>G:	MIR	rs2583974	0.1074	0.0000	0/0/0	0.1905							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90748374	90748374	A	C	hom		QUAL=10257;DP=319;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+920T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+920T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+920T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+920T>G:	MIR	rs2619355	0.7776	0.0000	0/0/0	0.7863							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90748488	90748488	T	C	hom		QUAL=9883;DP=301;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+806A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+806A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+806A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+806A>G:		rs2583975	0.7935	0.0000	0/0/0	0.7938							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				318	225					SNCA (inh=AD pLI=0.84)
chr4	90748646	90748646	C	G	hom		QUAL=9022;DP=272;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+648G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+648G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+648G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+648G>C:	(TCA)n	rs1442146	0.1074	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90748738	90748738	C	T	hom		QUAL=6463;DP=199;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+556G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+556G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+556G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+556G>A:		rs1442147	0.1078	0.0000	0/0/0	0.1907							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90748846	90748846	T	A	hom		QUAL=5281;DP=161;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+448A>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+448A>T:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+448A>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+448A>T:		rs1442148	0.7776	0.0000	0/0/0	0.7734							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				307	234					SNCA (inh=AD pLI=0.84)
chr4	90748958	90748958	-	CT	hom		QUAL=7918;DP=244;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+334_163+335dupAG:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+334_163+335dupAG:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+334_163+335dupAG:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+334_163+335dupAG:		rs34049266;rs71594900	0.0000	0.0000	0/0/0	0.1522							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90749132	90749132	A	T	hom		QUAL=4507;DP=134;AF=0.99;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon3/5:c.163+162T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon3/5:c.163+162T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon3/4:c.163+162T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon3/5:c.163+162T>A:		rs1442149	0.1074	0.0000	0/0/0	0.1599							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90749463	90749463	-	AAAAA	het		QUAL=2209;DP=127;AF=0.39;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-133_122-129dupTTTTT:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-133_122-129dupTTTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-133_122-129dupTTTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-133_122-129dupTTTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-133_122-129dupTTTTT:	(TA)n	rs149886412	0.0843	0.0000	0/0/0	0.1083							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				3	11					SNCA (inh=AD pLI=0.84)
chr4	90749469	90749469	-	AAAAAT	het		QUAL=2209;DP=127;AF=0.39;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-135_122-134insATTTTT:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-135_122-134insATTTTT:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-135_122-134insATTTTT:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-135_122-134insATTTTT:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-135_122-134insATTTTT:	(TA)n		0.0000	0.0000	0/0/0	0.0033							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90749686	90749686	A	G	hom		QUAL=13189;DP=405;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-351T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-351T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-351T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-351T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-351T>C:		rs2737006	0.1076	0.0000	0/0/0	0.1911							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90749803	90749804	AC	-	hom		QUAL=8673;DP=290;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-469_122-468delGT:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-469_122-468delGT:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-469_122-468delGT:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-469_122-468delGT:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-469_122-468delGT:	MIR	rs35510249	0.1074	0.0000	0/0/0	0.1055							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	28					SNCA (inh=AD pLI=0.84)
chr4	90750043	90750043	A	G	hom		QUAL=4323;DP=139;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-708T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-708T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-708T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-708T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-708T>C:	AluY	rs33965306	0.1078	0.0000	0/0/0	0.1908							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90750169	90750169	G	T	hom		QUAL=6228;DP=196;AF=0.97;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-834C>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-834C>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-834C>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-834C>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-834C>A:	MIRb	rs13142587	0.1074	0.0000	0/0/0	0.1886							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90750173	90750173	T	C	hom		QUAL=6228;DP=196;AF=0.97;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-838A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-838A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-838A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-838A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-838A>G:	MIRb	rs2583976	0.1074	0.0000	0/0/0	0.1886							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90750225	90750225	C	T	hom		QUAL=3256;DP=103;AF=0.98;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-890G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-890G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-890G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-890G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-890G>A:	MIRb	rs2583977	0.1076	0.0000	0/0/0	0.1902							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90750326	90750326	A	C	hom		QUAL=2058;DP=68;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-991T>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-991T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-991T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-991T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-991T>G:		rs2583978	0.7817	0.0000	0/0/0	0.7896							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				312	227					SNCA (inh=AD pLI=0.84)
chr4	90750588	90750588	A	T	hom		QUAL=8359;DP=267;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-1253T>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-1253T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-1253T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-1253T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-1253T>A:	Tigger6a	rs2583979	0.7819	0.0000	0/0/0	0.7395							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				314	228					SNCA (inh=AD pLI=0.84)
chr4	90750590	90750590	A	G	hom		QUAL=8359;DP=267;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-1255T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-1255T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-1255T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-1255T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-1255T>C:	Tigger6a	rs2737005	0.1074	0.0000	0/0/0	0.1413							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90750722	90750722	A	G	hom		QUAL=9859;DP=329;AF=0.98;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-1387T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-1387T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-1387T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-1387T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-1387T>C:	Tigger6a	rs2737004	0.1074	0.0000	0/0/0	0.1915							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90750844	90750844	C	T	hom		QUAL=13762;DP=418;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-1509G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-1509G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-1509G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-1509G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-1509G>A:	Tigger6a	rs2619356	0.7792	0.0000	0/0/0	0.7882							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				310	231					SNCA (inh=AD pLI=0.84)
chr4	90751109	90751109	T	G	hom		QUAL=14747;DP=464;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-1774A>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-1774A>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-1774A>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-1774A>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-1774A>C:	Tigger6a	rs2583980	0.1076	0.0000	0/0/0	0.1917							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90751415	90751415	C	G	hom		QUAL=9583;DP=298;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-2080G>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-2080G>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-2080G>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-2080G>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-2080G>C:	L1MA5	rs986609	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90751655	90751655	T	C	hom		QUAL=6011;DP=198;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-2320A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-2320A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-2320A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-2320A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-2320A>G:	L1MA5	rs986610	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	87					SNCA (inh=AD pLI=0.84)
chr4	90752205	90752205	T	C	hom		QUAL=4040;DP=126;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-2870A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-2870A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-2870A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-2870A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-2870A>G:	AluJb	rs2619357	0.8974	0.0000	0/0/0	0.7958							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				408	167					SNCA (inh=AD pLI=0.84)
chr4	90752582	90752582	A	T	hom		QUAL=7096;DP=226;AF=0.98;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-3247T>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-3247T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-3247T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-3247T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-3247T>A:	L1MA9	rs2583981	0.1076	0.0000	0/0/0	0.1913							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90752670	90752670	A	C	hom		QUAL=8547;DP=279;AF=0.97;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-3335T>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-3335T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-3335T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-3335T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-3335T>G:	L1MA9	rs2619358	0.1074	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90752973	90752973	-	A	hom		QUAL=2211;DP=75;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.122-3639_122-3638insT:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.122-3639_122-3638insT:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.122-3639_122-3638insT:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.122-3639_122-3638insT:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.122-3639_122-3638insT:	AluSg	rs34385672	0.1074	0.0000	0/0/0	0.1878							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90753068	90753068	A	G	hom		QUAL=1438;DP=46;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+3630T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+3630T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+3630T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+3630T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+3630T>C:	AluSg	rs2737003	0.1074	0.0000	0/0/0	0.1869							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90753180	90753180	A	G	hom		QUAL=2624;DP=80;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+3518T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+3518T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+3518T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+3518T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+3518T>C:	AluSg	rs2737002	0.7792	0.0000	0/0/0	0.7063							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				288	244					SNCA (inh=AD pLI=0.84)
chr4	90753244	90753244	T	C	hom		QUAL=3855;DP=122;AF=0.98;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+3454A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+3454A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+3454A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+3454A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+3454A>G:		rs2583982	0.1074	0.0000	0/0/0	0.1900							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90753339	90753339	A	T	het		QUAL=1191;DP=88;AF=0.51;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+3359T>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+3359T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+3359T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+3359T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+3359T>A:		rs55932807	0.0200	0.0000	0/0/0	0.0354							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	14					SNCA (inh=AD pLI=0.84)
chr4	90753477	90753477	G	A	hom		QUAL=7482;DP=227;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+3221C>T:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+3221C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+3221C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+3221C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+3221C>T:		rs2737001	0.1074	0.0000	0/0/0	0.1912							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90753960	90753960	C	T	hom		QUAL=9126;DP=280;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2738G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2738G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2738G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2738G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2738G>A:		rs2583983	0.1078	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754022	90754022	C	A	hom		QUAL=7541;DP=234;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2676G>T:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2676G>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2676G>T:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2676G>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2676G>T:		rs2737000	0.1074	0.0000	0/0/0	0.1909							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754111	90754111	A	G	hom		QUAL=7732;DP=246;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2587T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2587T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2587T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2587T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2587T>C:		rs2736999	0.1074	0.0000	0/0/0	0.1909							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754153	90754153	T	C	hom		QUAL=9032;DP=287;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2545A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2545A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2545A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2545A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2545A>G:		rs2583984	0.1076	0.0000	0/0/0	0.1913							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90754313	90754313	C	T	hom		QUAL=6490;DP=198;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2385G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2385G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2385G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2385G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2385G>A:	MIRb	rs1471484	0.7817	0.0000	0/0/0	0.7882							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				291	242					SNCA (inh=AD pLI=0.84)
chr4	90754336	90754336	C	A	hom		QUAL=6179;DP=198;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2362G>T:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2362G>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2362G>T:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2362G>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2362G>T:	MIRb	rs2736998	0.1074	0.0000	0/0/0	0.1880							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754557	90754557	G	A	hom		QUAL=12015;DP=389;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2141C>T:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2141C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2141C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2141C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2141C>T:	MER58A	rs2736997	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754622	90754622	-	TTTT	het		QUAL=1968;DP=245;AF=0.25;MQM=58	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2072_121+2075dupAAAA:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2072_121+2075dupAAAA:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2072_121+2075dupAAAA:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2072_121+2075dupAAAA:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2072_121+2075dupAAAA:	MER58A	rs779705304	0.0000	0.0000	0/0/0	0.0228							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				0	0					SNCA (inh=AD pLI=0.84)
chr4	90754632	90754632	C	T	hom		QUAL=1968;DP=245;AF=0.25;MQM=59	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2066G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2066G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2066G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2066G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2066G>A:	AluJb	rs10023587	0.0000	0.0000	0/0/0	0.1629							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				281	250					SNCA (inh=AD pLI=0.84)
chr4	90754691	90754691	A	G	hom		QUAL=4965;DP=179;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+2007T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+2007T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+2007T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+2007T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+2007T>C:	AluJb	rs2736996	0.1074	0.0000	0/0/0	0.1887							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90754771	90754771	A	G	hom		QUAL=3765;DP=124;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1927T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1927T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1927T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1927T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1927T>C:	AluJb	rs990085	0.7788	0.0000	0/0/0	0.7169							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				289	243					SNCA (inh=AD pLI=0.84)
chr4	90754828	90754828	A	C	hom		QUAL=4872;DP=156;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1870T>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1870T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1870T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1870T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1870T>G:	AluJb	rs2619359	0.1074	0.0000	0/0/0	0.1909							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90755090	90755090	A	T	hom		QUAL=5886;DP=177;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1608T>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1608T>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1608T>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1608T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1608T>A:		rs990086	0.1074	0.0000	0/0/0	0.1910							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90755177	90755177	A	C	hom		QUAL=6692;DP=208;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1521T>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1521T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1521T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1521T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1521T>G:		rs990087	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90755225	90755225	T	C	hom		QUAL=7690;DP=239;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1473A>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1473A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1473A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1473A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1473A>G:		rs990088	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90755605	90755605	-	A	hom		QUAL=8239;DP=325;AF=0.88;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+1092dupT:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+1092dupT:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+1092dupT:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+1092dupT:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+1092dupT:	FRAM	rs397813651	0.1076	0.0000	0/0/0	0.1551							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				5	86					SNCA (inh=AD pLI=0.84)
chr4	90755730	90755730	G	A	hom		QUAL=14250;DP=441;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+968C>T:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+968C>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+968C>T:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+968C>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+968C>T:		rs1372516	0.1074	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90755939	90755939	A	G	hom		QUAL=20549;DP=622;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+759T>C:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+759T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+759T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+759T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+759T>C:		rs2583985	0.1074	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90756191	90756191	C	T	hom		QUAL=15798;DP=480;AF=0.99;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+507G>A:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+507G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+507G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+507G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+507G>A:		rs2619360	0.1076	0.0000	0/0/0	0.1916							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84)
chr4	90756421	90756421	G	C	hom		QUAL=4135;DP=127;AF=1.00;MQM=60	SNCA	sequence_feature,intron	SNCA:NM_001146055.1:sequence_feature:LOW::c.121+277C>G:,SNCA:NM_000345.3:intron:MODIFIER:exon2/5:c.121+277C>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon2/5:c.121+277C>G:,SNCA:NM_007308.2:intron:MODIFIER:exon2/4:c.121+277C>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon2/5:c.121+277C>G:		rs2028535	0.1074	0.0000	0/0/0	0.1914							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	86					SNCA (inh=AD pLI=0.84)
chr4	90757294	90757294	A	C	hom		QUAL=16217;DP=511;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-25-451T>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-25-451T>G:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-25-451T>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-451T>G:		rs1372518	0.7762	0.0000	0/0/0	0.7568							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				437	315					SNCA (inh=AD pLI=0.84)
chr4	90757309	90757309	A	G	hom		QUAL=13036;DP=429;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-25-466T>C:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-25-466T>C:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-25-466T>C:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-466T>C:		rs1372519	0.7758	0.0000	0/0/0	0.7547							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				438	312					SNCA (inh=AD pLI=0.84)
chr4	90757505	90757505	T	C	hom		QUAL=13032;DP=403;AF=1.00;MQM=60	SNCA	intron	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+608A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-26+389A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-26+389A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-662A>G:		rs1372520	0.7780	0.0000	0/0/0	0.7831							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				285	248					SNCA (inh=AD pLI=0.84)
chr4	90757735	90757735	C	A	hom		QUAL=7642;DP=238;AF=1.00;MQM=60	SNCA,SNCA-AS1	intron,non_coding_transcript_exon	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+378G>T:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-26+159G>T:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-26+159G>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-892G>T:,SNCA-AS1:NR_045481.1:non_coding_transcript_exon:MODIFIER:exon1/4:n.184C>A:		rs2619361	0.1078	0.0000	0/0/0	0.1913							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				6	85					SNCA (inh=AD pLI=0.84), SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90757840	90757840	T	C	hom		QUAL=8281;DP=257;AF=1.00;MQM=60	SNCA,SNCA-AS1	intron,non_coding_transcript_exon	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+273A>G:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-26+54A>G:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-26+54A>G:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-997A>G:,SNCA-AS1:NR_045481.1:non_coding_transcript_exon:MODIFIER:exon1/4:n.289T>C:		rs2245801	0.7935	0.0000	0/0/0	0.7760							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				474	314					SNCA (inh=AD pLI=0.84), SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90757845	90757845	C	T	hom		QUAL=6668;DP=249;AF=0.97;MQM=60	SNCA,SNCA-AS1	intron,non_coding_transcript_exon	SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+268G>A:,SNCA:NM_001146054.1:intron:MODIFIER:exon1/5:c.-26+49G>A:,SNCA:NM_007308.2:intron:MODIFIER:exon1/4:c.-26+49G>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-1002G>A:,SNCA-AS1:NR_045481.1:non_coding_transcript_exon:MODIFIER:exon1/4:n.294C>T:		rs2619362	0.1078	0.0000	0/0/0	0.1733							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				25	176					SNCA (inh=AD pLI=0.84), SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90757947	90757947	T	A	hom		QUAL=6722;DP=237;AF=0.94;MQM=60	SNCA,SNCA-AS1	5'UTR,intron	SNCA:NM_001146054.1:5'UTR:MODIFIER:exon1/6:c.-79A>T:,SNCA:NM_007308.2:5'UTR:MODIFIER:exon1/5:c.-79A>T:,SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+166A>T:,SNCA-AS1:NR_045481.1:intron:MODIFIER:exon1/3:n.334+62T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-1104A>T:		rs2583986	0.1076	0.0000	0/0/0	0.0482							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				8	111					SNCA (inh=AD pLI=0.84), SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90757948	90757948	T	A	hom		QUAL=6722;DP=237;AF=0.94;MQM=60	SNCA,SNCA-AS1	5'UTR,intron	SNCA:NM_001146054.1:5'UTR:MODIFIER:exon1/6:c.-80A>T:,SNCA:NM_007308.2:5'UTR:MODIFIER:exon1/5:c.-80A>T:,SNCA:NM_000345.3:intron:MODIFIER:exon1/5:c.-26+165A>T:,SNCA-AS1:NR_045481.1:intron:MODIFIER:exon1/3:n.334+63T>A:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-25-1105A>T:		rs2245804	0.3409	0.0000	0/0/0	0.1370							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				28	281					SNCA (inh=AD pLI=0.84), SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90759047	90759047	G	T	hom		QUAL=6735;DP=231;AF=0.97;MQM=60	SNCA-AS1,SNCA	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon1/3:n.335-365G>T:,SNCA:NM_001146055.1:intron:MODIFIER:exon1/5:c.-26+356C>A:		rs2619363	0.1074	0.0000	0/0/0	0.1898							163890 [SNCA (confirmed) Parkinson disease 4,605543|Dementia,Lewy body,127750|Parkinson disease 1,168601];				24	166					SNCA-AS1 (inh=n/a pLI=n/a), SNCA (inh=AD pLI=0.84)
chr4	90759887	90759887	A	G	hom		QUAL=7165;DP=222;AF=1.00;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.480+330A>G:		rs2619364	0.1094	0.0000	0/0/0	0.1908											24	168					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90760175	90760177	TTT	-	het		QUAL=3857;DP=261;AF=0.21;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.480+631_480+633delTTT:	L1MC5		0.0000	0.0000	0/0/0	0.0000											0	35					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90760175	90760176	TT	-	het		QUAL=3857;DP=261;AF=0.51;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.480+632_480+633delTT:	L1MC5	rs10635705;rs796249174	0.1621	0.0000	0/0/0	0.1385											4	93					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90760221	90760221	A	C	hom		QUAL=7910;DP=260;AF=1.00;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.480+664A>C:	L1MC5	rs2583987	0.1092	0.0000	0/0/0	0.1903											24	166					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90760828	90760828	C	T	hom		QUAL=4651;DP=145;AF=0.99;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.480+1271C>T:		rs2583988	0.1092	0.0000	0/0/0	0.1903											24	156					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90761944	90761944	T	G	hom		QUAL=13002;DP=393;AF=1.00;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.481-548T>G:		rs983361	0.7584	0.0000	0/0/0	0.5819											345	270					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90762197	90762197	A	C	hom		QUAL=14133;DP=456;AF=0.98;MQM=60	SNCA-AS1	intron	SNCA-AS1:NR_045481.1:intron:MODIFIER:exon2/3:n.481-295A>C:		rs2736995	0.1092	0.0000	0/0/0	0.1904											7	89					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90762840	90762841	TT	-	het		QUAL=9927;DP=581;AF=0.18;MQM=60	SNCA-AS1	splice_region&intron	SNCA-AS1:NR_045481.1:splice_region&intron:LOW:exon3/3:n.541-11_541-10delTT:			0.0000	0.0000	0/0/0	0.0030											0	18					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90762840	90762840	T	-	het		QUAL=9927;DP=581;AF=0.66;MQM=60	SNCA-AS1	splice_region&intron	SNCA-AS1:NR_045481.1:splice_region&intron:LOW:exon3/3:n.541-10delT:		rs397696633	0.2165	0.0000	0/0/0	0.1588											0	311					SNCA-AS1 (inh=n/a pLI=n/a)
chr4	90763260	90763260	A	G	hom		QUAL=8265;DP=251;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90763260A>G:		rs2619366	0.1202	0.0000	0/0/0	0.1932											24	166					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90767095	90767095	A	C	hom		QUAL=8354;DP=262;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90767095A>C:		rs2619367	0.1092	0.0000	0/0/0	0.1648											6	87					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90767193	90767193	G	A	het		QUAL=369;DP=279;AF=0.18;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90767193G>A:	(GT)n	rs190621383	0.0216	0.0000	0/0/0	0.0194											0	25					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90767210	90767210	G	T	het		QUAL=885;DP=435;AF=0.19;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90767210G>T:	(AG)n	rs6824468	0.3047	0.0000	0/0/0	0.1230											8	252					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90767228	90767228	G	A	het		QUAL=4320;DP=305;AF=0.57;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90767228G>A:	(AG)n	rs79142528	0.0000	0.0000	0/0/0	0.0032											0	18					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90767230	90767230	A	G	het		QUAL=4320;DP=305;AF=0.57;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90767230A>G:	(AG)n	rs78228772	0.0000	0.0000	0/0/0	0.0133											0	102					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90769422	90769422	A	G	hom		QUAL=4013;DP=130;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90769422A>G:	AluJb	rs2583989	0.1202	0.0000	0/0/0	0.1930											6	86					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90771499	90771499	A	G	hom		QUAL=1687;DP=52;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90771499A>G:	THE1B-int	rs2583990	0.7308	0.0000	0/0/0	0.7565											230	257					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90772851	90772851	A	C	hom		QUAL=13147;DP=417;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90772851A>C:	LTR50	rs2736993	0.1090	0.0000	0/0/0	0.1905											6	86					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90774724	90774724	G	A	hom		QUAL=7434;DP=233;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90774724G>A:		rs1551980	0.1094	0.0000	0/0/0	0.1878											6	87					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90775649	90775649	C	A	hom		QUAL=16298;DP=493;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90775649C>A:	MSTB1	rs1442152	0.7286	0.0000	0/0/0	0.7514											231	270					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90776257	90776257	T	C	hom		QUAL=10946;DP=336;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90776257T>C:		rs2736989	0.7308	0.0000	0/0/0	0.7560											232	269					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90776345	90776345	C	T	hom		QUAL=10642;DP=328;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90776345C>T:		rs2736988	0.1202	0.0000	0/0/0	0.1935											6	87					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90777213	90777213	C	T	hom		QUAL=14268;DP=442;AF=0.99;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90777213C>T:		rs2737035	0.1094	0.0000	0/0/0	0.1904											6	86					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90777464	90777464	C	G	hom		QUAL=1926;DP=62;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90777464C>G:	L1P1	rs2737034	0.1092	0.0000	0/0/0	0.1895											6	86					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90777468	90777468	G	C	hom		QUAL=1926;DP=62;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90777468G>C:	L1P1	rs2619339	0.1092	0.0000	0/0/0	0.1895											6	86					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90779518	90779518	G	C	hom	low_DP	QUAL=239;DP=9;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90779518G>C:	L1PA5	rs2619340	0.1090	0.0000	0/0/0	0.1594											7	73					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90779755	90779755	A	G	hom		QUAL=2897;DP=93;AF=0.98;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90779755A>G:		rs2737027	1.0000	0.0000	0/0/0	0.7976											593	0					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90779758	90779758	A	G	hom		QUAL=2897;DP=93;AF=0.98;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90779758A>G:		rs2583961	0.7294	0.0000	0/0/0	0.6245											233	267					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90779823	90779823	A	G	hom		QUAL=8163;DP=258;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90779823A>G:		rs2737026	0.7294	0.0000	0/0/0	0.7437											230	271					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr4	90784528	90784528	A	G	hom		QUAL=19297;DP=598;AF=1.00;MQM=60	SNCA-AS1-MMRN1	intergenic_region	SNCA-AS1-MMRN1:SNCA-AS1-MMRN1:intergenic_region:MODIFIER::n.90784528A>G:		rs2736994	0.7660	0.0000	0/0/0	0.7772											277	248					SNCA-AS1-MMRN1 (inh=n/a pLI=n/a)
chr12	40574969	40574969	C	T	hom		QUAL=5631;DP=178;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40574969C>T:	AluYm1	rs2244780	0.9836	0.0000	0/0/0	0.8697											591	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575067	40575067	-	TGGAGCT	hom		QUAL=3881;DP=130;AF=0.97;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575067_40575068insTGGAGCT:	AluYm1	rs139872131;rs3057558	0.9435	0.0000	0/0/0	0.8173											551	40					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575086	40575086	G	A	hom		QUAL=5592;DP=175;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575086G>A:	AluYm1	rs2708402	0.9836	0.0000	0/0/0	0.5071											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575137	40575137	A	-	hom		QUAL=7653;DP=261;AF=0.95;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575137delA:	AluYm1	rs869205118	0.8756	0.0000	0/0/0	0.6631											519	71					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575217	40575217	A	G	hom		QUAL=13492;DP=411;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575217A>G:	MER72	rs2708403	0.9836	0.0000	0/0/0	0.8743											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575630	40575630	G	A	hom		QUAL=12259;DP=373;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575630G>A:	MIR	rs2708404	0.8460	0.0000	0/0/0	0.7383											382	190					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575783	40575783	G	A	hom		QUAL=12420;DP=385;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575783G>A:	MIR3	rs2708405	0.9836	0.0000	0/0/0	0.8743											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40575906	40575906	G	A	hom		QUAL=11003;DP=329;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40575906G>A:		rs2708406	0.9836	0.0000	0/0/0	0.8731											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40576117	40576117	T	G	hom		QUAL=9156;DP=282;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40576117T>G:	AluJb	rs2638240	0.9836	0.0000	0/0/0	0.8730											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40576253	40576253	G	T	hom		QUAL=8721;DP=275;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40576253G>T:	AluJb	rs2952711	0.8698	0.0000	0/0/0	0.8246											448	140					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40576386	40576386	-	AAAATAAAATAAAATAAAAT	het		QUAL=845;DP=47;AF=0.49;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40576386_40576387insAAAATAAAATAAAATAAAAT:		rs71434311	0.9643	0.0000	0/0/0	0.1910											2	14					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40576386	40576386	-	AAAATAAAAT	het		QUAL=845;DP=47;AF=0.49;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40576386_40576387insAAAATAAAAT:		rs71434311	0.0000	0.0000	0/0/0	0.0376											87	148					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40576708	40576708	G	C	hom		QUAL=14059;DP=427;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40576708G>C:		rs2244534	0.9836	0.0000	0/0/0	0.8670											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40577696	40577696	T	A	het		QUAL=7495;DP=506;AF=0.54;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40577696T>A:	MER4D1	rs2638239	0.3387	0.0000	0/0/0	0.4052											113	290					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40577719	40577719	T	C	het		QUAL=6439;DP=544;AF=0.46;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40577719T>C:	MER4D1	rs2404577	0.2598	0.0000	0/0/0	0.2429											13	137					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40577791	40577791	A	G	het		QUAL=8236;DP=625;AF=0.49;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40577791A>G:	MER4D1	rs2404578	0.1122	0.0000	0/0/0	0.1326											5	81					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40578022	40578022	A	C	hom		QUAL=7340;DP=237;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40578022A>C:	MER4D1	rs2244389	0.9836	0.0000	0/0/0	0.8722											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40578888	40578888	G	A	hom		QUAL=4373;DP=134;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40578888G>A:	L2a	rs2708407	0.9836	0.0000	0/0/0	0.8655											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40579612	40579612	A	G	hom		QUAL=12952;DP=389;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40579612A>G:		rs2244170	0.9836	0.0000	0/0/0	0.8737											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40579937	40579937	C	T	hom		QUAL=9422;DP=296;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40579937C>T:		rs2244159	0.9836	0.0000	0/0/0	0.8738											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40580269	40580269	G	T	hom		QUAL=7952;DP=258;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40580269G>T:		rs2244149	0.9836	0.0000	0/0/0	0.8732											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40580282	40580282	T	-	hom		QUAL=6009;DP=213;AF=0.93;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40580282delT:		rs869182456	0.9804	0.0000	0/0/0	0.7225											568	25					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40580440	40580440	G	A	het		QUAL=3700;DP=319;AF=0.46;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40580440G>A:		rs2046932	0.0609	0.0000	0/0/0	0.0678											12	136					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40580874	40580874	T	C	hom		QUAL=15086;DP=463;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40580874T>C:	MIR3	rs2638238	0.9836	0.0000	0/0/0	0.9107											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40581231	40581231	A	C	hom		QUAL=14570;DP=457;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40581231A>C:	MER4A1	rs2708408	0.9691	0.0000	0/0/0	0.8518											511	76					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40581794	40581794	G	A	hom		QUAL=15287;DP=455;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40581794G>A:	MER4-int	rs2708409	0.9836	0.0000	0/0/0	0.8725											592	2					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40582224	40582224	A	C	hom		QUAL=3201;DP=103;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40582224A>C:	AluSx1	rs2708410	0.9836	0.0000	0/0/0	0.8739											592	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40582251	40582251	A	G	hom		QUAL=3227;DP=102;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40582251A>G:	AluSx1	rs2708411	0.9836	0.0000	0/0/0	0.8725											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40582828	40582828	-	AG	hom		QUAL=4906;DP=152;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40582828_40582829insAG:	MER4-int	rs397819763;rs55857216	0.0000	0.0000	0/0/0	0.7228											590	3					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40582935	40582935	C	T	hom		QUAL=3499;DP=109;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40582935C>T:	MER4-int	rs2263417	0.9836	0.0000	0/0/0	0.8723											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40582993	40582993	A	G	hom		QUAL=3218;DP=99;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40582993A>G:	MER4-int	rs2263418	0.8255	0.0000	0/0/0	0.8013											378	187					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40583099	40583099	T	G	hom		QUAL=2216;DP=74;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40583099T>G:	MER4-int	rs1844922	0.3512	0.0000	0/0/0	0.4109											112	289					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40583466	40583466	A	G	hom		QUAL=4911;DP=152;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40583466A>G:	MER4-int	rs2638237	0.9836	0.0000	0/0/0	0.8683											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40583566	40583566	C	T	hom		QUAL=7914;DP=234;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40583566C>T:	MER4-int	rs2638236	0.8512	0.0000	0/0/0	0.7669											433	137					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40583826	40583826	T	C	het		QUAL=3692;DP=297;AF=0.47;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40583826T>C:	MER4-int	rs7969112	0.2586	0.0000	0/0/0	0.2417											13	139					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40583885	40583885	A	T	het		QUAL=4167;DP=328;AF=0.48;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40583885A>T:	MER4-int	rs7966132	0.1112	0.0000	0/0/0	0.1201											5	82					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40584553	40584553	A	G	het		QUAL=3317;DP=301;AF=0.44;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40584553A>G:	MER4-int	rs73102246	0.0002	0.0000	0/0/0	0.0001											0	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40584603	40584603	A	T	hom		QUAL=10968;DP=329;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40584603A>T:	MER4-int	rs2638235	0.9836	0.0000	0/0/0	0.8691											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40584921	40584921	T	C	hom		QUAL=2837;DP=94;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40584921T>C:	AluY	rs2708413	0.9976	0.0000	0/0/0	0.8617											592	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40585233	40585233	G	A	het		QUAL=2994;DP=218;AF=0.52;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40585233G>A:	PABL_A-int	rs1602577	0.0607	0.0000	0/0/0	0.0641											12	137					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40585304	40585304	T	C	hom		QUAL=9070;DP=276;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40585304T>C:	LTR8	rs2708415	0.9836	0.0000	0/0/0	0.8587											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40586161	40586161	A	G	hom		QUAL=12194;DP=382;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40586161A>G:	PABL_A-int	rs2708416	0.9836	0.0000	0/0/0	0.8672											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40586585	40586585	T	-	het		QUAL=1022;DP=676;AF=0.18;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40586585delT:	PABL_A-int		0.0000	0.0000	0/0/0	0.0030											0	1					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40587055	40587055	C	A	hom		QUAL=11119;DP=351;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40587055C>A:	PABL_A-int	rs2254475	0.9379	0.0000	0/0/0	0.8610											595	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40587636	40587636	-	CAACAA	het		QUAL=7430;DP=346;AF=0.44;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40587636_40587637insCAACAA:	(AAC)n		0.0000	0.0000	0/0/0	0.0000											0	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40587636	40587636	C	A	hom		QUAL=7430;DP=346;AF=0.44;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40587636C>A:	(AAC)n	rs2708417	0.0000	0.0000	0/0/0	0.4709											301	262					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40587702	40587702	T	C	hom		QUAL=15607;DP=494;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40587702T>C:	MER4-int	rs1844921	0.3484	0.0000	0/0/0	0.4057											113	290					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40590304	40590304	-	AC	hom		QUAL=333;DP=176;AF=0.35;MQM=59	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40590304_40590305insAC:			0.0000	0.0000	0/0/0	0.0002											0	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40592225	40592225	A	G	hom		QUAL=11069;DP=344;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40592225A>G:	Tigger2a	rs2708418	0.6298	0.0000	0/0/0	0.6613											380	189					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40592388	40592388	C	T	het		QUAL=3273;DP=267;AF=0.48;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40592388C>T:	AluJr	rs2708419	0.6338	0.0000	0/0/0	0.5971											375	194					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40592501	40592501	G	T	hom		QUAL=4729;DP=146;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40592501G>T:	AluJr	rs2708420	0.6484	0.0000	0/0/0	0.5822											380	190					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40593403	40593403	C	T	het		QUAL=4554;DP=439;AF=0.43;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40593403C>T:		rs2708421	0.5317	0.0000	0/0/0	0.5564											190	295					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40593676	40593676	T	C	hom		QUAL=10519;DP=320;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40593676T>C:	AluJr	rs2708422	0.6482	0.0000	0/0/0	0.6032											380	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40594173	40594173	G	AA	het		QUAL=5978;DP=272;AF=0.36;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40594173delGinsAA:	SVA_E		0.0000	0.0000	0/0/0	0.0299											0	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40594173	40594173	G	A	het		QUAL=5978;DP=272;AF=0.49;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40594173G>A:	SVA_E	rs2708423	0.6482	0.0000	0/0/0	0.1507											379	187					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40594570	40594570	C	T	hom		QUAL=7912;DP=243;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40594570C>T:	L1M3	rs2708424	0.6847	0.0000	0/0/0	0.6682											380	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40594722	40594722	C	A	hom		QUAL=12293;DP=379;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40594722C>A:	L1M3	rs2638233	0.6494	0.0000	0/0/0	0.6576											380	192					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40595542	40595542	C	T	hom		QUAL=7719;DP=237;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40595542C>T:		rs2723266	0.9675	0.0000	0/0/0	0.8569											593	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40596166	40596166	A	T	hom		QUAL=8319;DP=260;AF=0.98;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40596166A>T:		rs1491934	0.8075	0.0000	0/0/0	0.3909											339	220					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40597152	40597156	TTTTC	-	hom		QUAL=8379;DP=349;AF=0.81;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40597152_40597156delTTTTC:	THE1D	rs149273546;rs149618323	0.0000	0.0000	0/0/0	0.5182											392	176					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40597209	40597229	TTTTTTTTTTTTTTTTTTTTT	-	hom		QUAL=978;DP=271;AF=0.36;MQM=59	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40597209_40597229delTTTTTTTTTTTTTTTTTTTTT:	THE1D:AluSq4	rs764274920	0.0000	0.0000	0/0/0	0.2084											2	1					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40597247	40597247	T	G	hom		QUAL=978;DP=271;AF=0.36;MQM=59	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40597247T>G:	AluSq4	rs2708425	0.0000	0.0000	0/0/0	0.0798											512	76					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40597545	40597545	T	G	hom		QUAL=1759;DP=62;AF=0.97;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40597545T>G:	THE1D	rs4768221	0.3425	0.0000	0/0/0	0.4085											102	296					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40597869	40597869	T	C	hom		QUAL=7246;DP=227;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40597869T>C:	FRAM	rs4767967	0.3407	0.0000	0/0/0	0.3805											100	299					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40598344	40598344	A	T	hom		QUAL=12933;DP=384;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40598344A>T:		rs1491940	0.6002	0.0000	0/0/0	0.6174											296	255					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40598939	40598939	C	T	hom		QUAL=6268;DP=190;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40598939C>T:		rs2708427	0.6000	0.0000	0/0/0	0.5844											296	254					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40600696	40600696	G	A	hom		QUAL=6806;DP=213;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40600696G>A:		rs2723259	0.6494	0.0000	0/0/0	0.6565											380	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40600942	40600942	C	T	hom		QUAL=7710;DP=241;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40600942C>T:	FLAM_C	rs2131086	0.5371	0.0000	0/0/0	0.5101											193	294					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40601808	40601808	C	T	hom		QUAL=13035;DP=392;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40601808C>T:		rs2723261	0.6000	0.0000	0/0/0	0.6186											295	256					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40602224	40602224	T	G	hom		QUAL=8775;DP=271;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40602224T>G:		rs1491932	0.6494	0.0000	0/0/0	0.6577											380	192					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40603316	40603316	T	C	hom		QUAL=10981;DP=333;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40603316T>C:	L2c	rs2279535	0.6849	0.0000	0/0/0	0.6690											380	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40603957	40603957	T	C	hom		QUAL=15393;DP=483;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40603957T>C:	MamGypLTR1b	rs2708429	0.9694	0.0000	0/0/0	0.8712											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40604068	40604068	A	G	hom		QUAL=10843;DP=336;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40604068A>G:	MamGypLTR1b	rs2638229	0.6002	0.0000	0/0/0	0.6186											298	254					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40604075	40604075	T	G	hom		QUAL=10738;DP=336;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40604075T>G:	MamGypLTR1b	rs2638230	0.6538	0.0000	0/0/0	0.6595											381	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40604608	40604608	C	A	hom		QUAL=1451;DP=50;AF=0.98;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40604608C>A:	(TA)n	rs10784428	0.3848	0.0000	0/0/0	0.3223											98	298					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40605916	40605916	G	A	hom		QUAL=2235;DP=72;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40605916G>A:	AluSg	rs2263419	0.6494	0.0000	0/0/0	0.6032											380	189					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40606007	40606007	C	T	hom		QUAL=5650;DP=181;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40606007C>T:	AluSg	rs2263420	0.6494	0.0000	0/0/0	0.6040											380	190					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40606232	40606234	TTG	-	hom		QUAL=3981;DP=131;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40606232_40606234delTTG:	MER4-int	rs141392914	0.6494	0.0000	0/0/0	0.5956											379	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40607098	40607098	G	A	hom		QUAL=9255;DP=279;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40607098G>A:	MER4-int	rs2201141	0.6496	0.0000	0/0/0	0.6577											380	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40607460	40607460	C	T	het		QUAL=3786;DP=307;AF=0.48;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40607460C>T:	MER4-int	rs55663860	0.0020	0.0000	0/0/0	0.0050											0	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40607526	40607526	G	C	hom		QUAL=12926;DP=398;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40607526G>C:	MER4A1	rs2723256	0.9675	0.0000	0/0/0	0.8705											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40607647	40607647	C	T	hom		QUAL=9496;DP=288;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40607647C>T:	MER4A1	rs1388594	0.5142	0.0000	0/0/0	0.5542											191	295					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40608880	40608880	C	T	hom		QUAL=12432;DP=395;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40608880C>T:	L2c	rs10878220	0.3423	0.0000	0/0/0	0.4085											102	299					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40609883	40609883	G	A	hom		QUAL=12713;DP=391;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40609883G>A:		rs2638272	0.6158	0.0000	0/0/0	0.6481											379	191					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40609979	40609979	C	T	hom		QUAL=10404;DP=332;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40609979C>T:	L2c	rs12827541	0.3582	0.0000	0/0/0	0.4138											99	299					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40610098	40610098	A	T	hom		QUAL=10710;DP=334;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40610098A>T:		rs2708433	0.9694	0.0000	0/0/0	0.8703											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40610221	40610221	G	C	hom		QUAL=9658;DP=294;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40610221G>C:	MamRep605	rs2638273	0.9689	0.0000	0/0/0	0.8713											594	0					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40610718	40610718	G	A	hom		QUAL=8315;DP=249;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40610718G>A:		rs10878222	0.3407	0.0000	0/0/0	0.4082											98	300					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40612162	40612162	-	T	hom		QUAL=7510;DP=330;AF=0.81;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40612162_40612163insT:		rs63538463;rs869159518	0.8774	0.0000	0/0/0	0.6373											147	446					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40613997	40613997	T	G	hom		QUAL=2419;DP=83;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40613997T>G:	(AT)n	rs1602578	0.3586	0.0000	0/0/0	0.2936											101	295					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40614601	40614601	C	T	hom		QUAL=10117;DP=308;AF=1.00;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40614601C>T:	AluJr4	rs10878224	0.3452	0.0000	0/0/0	0.3814											98	300					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40614656	40614656	A	G	hom		QUAL=9414;DP=292;AF=0.99;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40614656A>G:	AluJr4	rs2708435	0.6170	0.0000	0/0/0	0.5910											381	189					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40614928	40614928	T	-	het		QUAL=279;DP=126;AF=0.19;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40614928delT:	L1M5:AluSz		0.0000	0.0000	0/0/0	0.0005											0	23					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40615069	40615069	C	T	hom		QUAL=3137;DP=108;AF=0.98;MQM=60	SLC2A13-LRRK2	intergenic_region	SLC2A13-LRRK2:SLC2A13-LRRK2:intergenic_region:MODIFIER::n.40615069C>T:	AluSz	rs10748014	0.3441	0.0000	0/0/0	0.3816											97	299					SLC2A13-LRRK2 (inh=n/a pLI=n/a)
chr12	40619082	40619082	G	A	hom		QUAL=18601;DP=590;AF=1.00;MQM=60	LRRK2	missense&splice_region	LRRK2:NM_198578.3:missense&splice_region:MODERATE:exon1/51:c.149G>A:p.Arg50His		rs2256408	0.9692	0.9911	59581/33321/4188	0.9372	0.2040	T,T	T	B	T,T	13.86	609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032408.1 [uncertain significance]; 			2340	1					LRRK2 (inh=AD pLI=0.00)
chr12	40619301	40619301	G	A	hom		QUAL=15017;DP=470;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon1/50:c.152-56G>A:		rs2723273	0.9692	0.0000	0/0/0	0.1768							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1145	1					LRRK2 (inh=AD pLI=0.00)
chr12	40619542	40619542	A	G	hom		QUAL=15093;DP=468;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.237+100A>G:		rs2256286	0.9692	0.0000	0/0/0	0.1488							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				607	0					LRRK2 (inh=AD pLI=0.00)
chr12	40620755	40620755	C	-	het		QUAL=4637;DP=378;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.237+1314delC:		rs144635285	0.0124	0.0000	0/0/0	0.0187							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	3					LRRK2 (inh=AD pLI=0.00)
chr12	40620815	40620815	G	A	hom		QUAL=15835;DP=504;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.237+1373G>A:		rs1491941	0.6575	0.0000	0/0/0	0.6607							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				500	309					LRRK2 (inh=AD pLI=0.00)
chr12	40622235	40622235	-	T	het		QUAL=135;DP=201;AF=0.19;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.237+2815dupT:	L1MA4	rs376594780	0.0000	0.0000	0/0/0	0.0012							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	3					LRRK2 (inh=AD pLI=0.00)
chr12	40623307	40623307	T	A	hom		QUAL=12854;DP=386;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-2769T>A:		rs2708439	0.9692	0.0000	0/0/0	0.8455							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40623730	40623730	C	T	hom		QUAL=7532;DP=238;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-2346C>T:		rs2708440	0.9692	0.0000	0/0/0	0.8699							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40623755	40623755	G	A	hom		QUAL=5088;DP=178;AF=0.97;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-2321G>A:		rs11175656	0.3413	0.0000	0/0/0	0.1946							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				97	302					LRRK2 (inh=AD pLI=0.00)
chr12	40624083	40624083	A	T	het		QUAL=3153;DP=272;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-1993A>T:		rs73106332	0.0018	0.0000	0/0/0	0.0052							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	0					LRRK2 (inh=AD pLI=0.00)
chr12	40625192	40625192	-	AAAA	hom		QUAL=467;DP=70;AF=0.27;MQM=56	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-868_238-865dupAAAA:	AluJr		0.0000	0.0000	0/0/0	0.0007							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	7					LRRK2 (inh=AD pLI=0.00)
chr12	40625378	40625378	-	A	het		QUAL=1608;DP=229;AF=0.34;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon2/50:c.238-682dupA:	AluJr	rs569480376	0.0000	0.0000	0/0/0	0.0047							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	53					LRRK2 (inh=AD pLI=0.00)
chr12	40626230	40626230	T	C	hom		QUAL=11358;DP=344;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon3/50:c.347+45T>C:		rs1352879	0.9373	0.9823	57892/32913/3333	0.9224							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1329	0					LRRK2 (inh=AD pLI=0.00)
chr12	40626285	40626285	C	T	hom		QUAL=7726;DP=235;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon3/50:c.347+100C>T:		rs1352878	0.9375	0.0000	0/0/0	0.1800							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				639	0					LRRK2 (inh=AD pLI=0.00)
chr12	40626689	40626689	A	C	hom		QUAL=7904;DP=248;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon3/50:c.347+504A>C:		rs2723267	0.9692	0.0000	0/0/0	0.8579							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				593	0					LRRK2 (inh=AD pLI=0.00)
chr12	40627871	40627871	A	G	hom		QUAL=14270;DP=444;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon3/50:c.348-1557A>G:		rs2252434	0.9692	0.0000	0/0/0	0.8707							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40629595	40629595	G	T	het		QUAL=366;DP=196;AF=0.24;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon4/50:c.436+79G>T:		rs878915406	0.0000	0.0000	0/0/0	0.0004							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	6					LRRK2 (inh=AD pLI=0.00)
chr12	40631358	40631358	T	C	hom		QUAL=17417;DP=529;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon4/50:c.437-413T>C:		rs2249281	0.9291	0.0000	0/0/0	0.8975							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40631626	40631629	AACA	-	hom		QUAL=6834;DP=227;AF=0.97;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon4/50:c.437-124_437-121delACAA:	(AACA)n	rs138000936;rs147104788	0.4507	0.0000	0/0/0	0.4518							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				205	300					LRRK2 (inh=AD pLI=0.00)
chr12	40631791	40631791	T	C	hom		QUAL=14069;DP=431;AF=0.99;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon5/51:c.457T>C:p.Leu153Leu		rs10878245	0.4529	0.5263	17649/11658/785	0.5239							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032466.2 [other]; 		COSM1128598, COSM1128599	812	1116	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40632958	40632958	G	T	hom		QUAL=10346;DP=328;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon5/50:c.571+1053G>T:	L4_A_Mam:L4_B_Mam	rs954884	0.4469	0.0000	0/0/0	0.5300							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				224	292					LRRK2 (inh=AD pLI=0.00)
chr12	40633314	40633314	T	C	hom		QUAL=16009;DP=514;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon5/50:c.572-971T>C:		rs10878249	0.3391	0.0000	0/0/0	0.3911							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				124	291					LRRK2 (inh=AD pLI=0.00)
chr12	40633488	40633488	G	A	hom		QUAL=9909;DP=300;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon5/50:c.572-797G>A:		rs10784444	0.4471	0.0000	0/0/0	0.5321							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				224	291					LRRK2 (inh=AD pLI=0.00)
chr12	40635858	40635858	T	C	hom		QUAL=4672;DP=153;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon6/50:c.706+1439T>C:		rs2723271	0.9978	0.0000	0/0/0	0.8784							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				593	0					LRRK2 (inh=AD pLI=0.00)
chr12	40639561	40639561	A	G	het		QUAL=2372;DP=180;AF=0.52;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.838+2078A>G:	L1ME3F	rs2404580	0.4311	0.0000	0/0/0	0.4899							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				215	292					LRRK2 (inh=AD pLI=0.00)
chr12	40639901	40639901	C	T	het		QUAL=3040;DP=218;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.838+2418C>T:		rs2404581	0.4908	0.0000	0/0/0	0.4597							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				271	259					LRRK2 (inh=AD pLI=0.00)
chr12	40640126	40640126	G	T	hom		QUAL=6453;DP=196;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.838+2643G>T:	L1ME3F	rs2723272	0.9657	0.0000	0/0/0	0.8401							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				592	0					LRRK2 (inh=AD pLI=0.00)
chr12	40640160	40640160	T	C	het		QUAL=3209;DP=231;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.838+2677T>C:	L1ME3F	rs1388599	0.0493	0.0000	0/0/0	0.0656							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	24					LRRK2 (inh=AD pLI=0.00)
chr12	40641232	40641234	CTA	-	het		QUAL=763;DP=82;AF=0.49;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.839-2394_839-2392delACT:		rs10544982	0.4932	0.0000	0/0/0	0.4149							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				250	260					LRRK2 (inh=AD pLI=0.00)
chr12	40641329	40641329	A	G	het	low_QUAL;low_DP	QUAL=6;DP=13;AF=0.23;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.839-2299A>G:		rs2708442	0.0000	0.0000	0/0/0	0.0006							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				7	12					LRRK2 (inh=AD pLI=0.00)
chr12	40641517	40641550	TATATAAATATACAAATATAAATATATACATTTA	-	het	low_DP	QUAL=179;DP=15;AF=0.80;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.839-2097_839-2064delAATATAAATATATACATTTATATATAAATATACA:			0.0000	0.0000	0/0/0	0.0000							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	1					LRRK2 (inh=AD pLI=0.00)
chr12	40641692	40641692	A	G	het		QUAL=2453;DP=242;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.839-1936A>G:	MIRb	rs10878258	0.1691	0.0000	0/0/0	0.2270							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	120					LRRK2 (inh=AD pLI=0.00)
chr12	40643468	40643468	C	T	het		QUAL=1869;DP=187;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon7/50:c.839-160C>T:		rs732374	0.3199	0.0000	0/0/0	0.0698							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				113	285					LRRK2 (inh=AD pLI=0.00)
chr12	40644046	40644046	A	C	hom		QUAL=4858;DP=154;AF=1.00;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.958+299A>C:	AluSq4	rs2723263	0.9653	0.0000	0/0/0	0.8696							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				592	0					LRRK2 (inh=AD pLI=0.00)
chr12	40644203	40644203	T	A	hom		QUAL=4136;DP=137;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.958+456T>A:	AluSq4	rs2723262	0.9657	0.0000	0/0/0	0.8691							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				592	0					LRRK2 (inh=AD pLI=0.00)
chr12	40644279	40644279	T	C	het		QUAL=3217;DP=240;AF=0.52;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.958+532T>C:	AluSq4	rs10878262	0.3199	0.0000	0/0/0	0.3272							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				113	286					LRRK2 (inh=AD pLI=0.00)
chr12	40644305	40644305	T	C	het		QUAL=3241;DP=239;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.958+558T>C:		rs12371502	0.4297	0.0000	0/0/0	0.5012							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				210	297					LRRK2 (inh=AD pLI=0.00)
chr12	40644804	40644804	-	T	het		QUAL=2746;DP=302;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.959-216dupT:			0.0000	0.0000	0/0/0	0.0105							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	26					LRRK2 (inh=AD pLI=0.00)
chr12	40644874	40644874	C	T	het		QUAL=3920;DP=283;AF=0.53;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon8/50:c.959-160C>T:		rs7134379	0.1703	0.0000	0/0/0	0.2248							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				8	121					LRRK2 (inh=AD pLI=0.00)
chr12	40645257	40645257	C	A	het		QUAL=5174;DP=473;AF=0.43;MQM=60	LRRK2	splice_region&intron	LRRK2:NM_198578.3:splice_region&intron:LOW:exon9/50:c.1102-10C>A:		rs7955902	0.3195	0.3622	7529/4483/214	0.3498							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000281737.1 [benign]; 			380	1080					LRRK2 (inh=AD pLI=0.00)
chr12	40645630	40645630	G	A	het		QUAL=6058;DP=486;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon10/50:c.1181+284G>A:		rs1491938	0.4291	0.0000	0/0/0	0.5017							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				212	296					LRRK2 (inh=AD pLI=0.00)
chr12	40645772	40645772	A	T	hom		QUAL=11340;DP=351;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon10/50:c.1181+426A>T:		rs2708444	0.9651	0.0000	0/0/0	0.8702							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40649323	40649323	C	T	hom		QUAL=9447;DP=282;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon11/50:c.1289-1727C>T:		rs2723265	0.9225	0.0000	0/0/0	0.8579							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				593	0					LRRK2 (inh=AD pLI=0.00)
chr12	40649975	40649975	G	A	het		QUAL=1771;DP=149;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon11/50:c.1289-1075G>A:	AluJo	rs10784452	0.2240	0.0000	0/0/0	0.2370							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	136					LRRK2 (inh=AD pLI=0.00)
chr12	40652394	40652394	A	G	het		QUAL=3658;DP=320;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon12/50:c.1419-888A>G:	L2c	rs2046928	0.0727	0.0000	0/0/0	0.0831							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40652520	40652520	T	C	hom		QUAL=6615;DP=215;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon12/50:c.1419-762T>C:	L2c	rs2723264	0.8199	0.0000	0/0/0	0.8170							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				471	115					LRRK2 (inh=AD pLI=0.00)
chr12	40655016	40655016	T	C	het		QUAL=3431;DP=284;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon13/50:c.1543+1610T>C:		rs11175766	0.0683	0.0000	0/0/0	0.0853							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40655707	40655707	C	T	het		QUAL=2221;DP=164;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon13/50:c.1544-1884C>T:		rs11564183	0.0767	0.0000	0/0/0	0.0888							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40656962	40656962	T	A	het		QUAL=1821;DP=154;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon13/50:c.1544-629T>A:		rs17490817	0.0994	0.0000	0/0/0	0.0949							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40657203	40657203	-	A	hom		QUAL=6731;DP=228;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon13/50:c.1544-388_1544-387insA:		rs11430638	0.8598	0.0000	0/0/0	0.7404							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				448	135					LRRK2 (inh=AD pLI=0.00)
chr12	40657700	40657700	C	G	het	pred_pathogenic	QUAL=5817;DP=448;AF=0.49;MQM=60	LRRK2	missense	LRRK2:NM_198578.3:missense:MODERATE:exon14/51:c.1653C>G:p.Asn551Lys		rs7308720	0.0994	0.0861	559/225/96	0.0866	0.2240	D,D,D	T	B,D	T,T,T	27.30	609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032413.2 [other]; 	CM104618 [CLASS=DFP MUT=ALT PHEN="Parkinson disease reduced risk association with" GENE=LRRK2]; 		11	251	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40659096	40659096	C	T	het		QUAL=6477;DP=529;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+1393C>T:		rs11175780	0.0667	0.0000	0/0/0	0.0809							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40659706	40659706	C	G	het	low_MQM	QUAL=362;DP=40;AF=0.45;MQM=41	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+2003C>G:	L1PA4	rs17490865	0.0619	0.0000	0/0/0	0.0637							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				4	54					LRRK2 (inh=AD pLI=0.00)
chr12	40660617	40660617	A	T	hom	low_DP	QUAL=488;DP=17;AF=1.00;MQM=57	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+2914A>T:	L1PA4	rs12317068	0.6867	0.0000	0/0/0	0.3614							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				329	189					LRRK2 (inh=AD pLI=0.00)
chr12	40660738	40660738	A	G	het		QUAL=163;DP=25;AF=0.44;MQM=58	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+3035A>G:	L1PA4	rs111341533	0.1164	0.0000	0/0/0	0.0890							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	25					LRRK2 (inh=AD pLI=0.00)
chr12	40661053	40661053	A	T	het		QUAL=3103;DP=215;AF=0.52;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+3350A>T:	LTR43	rs73108329	0.0609	0.0000	0/0/0	0.0831							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40661281	40661281	T	C	het		QUAL=4279;DP=342;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+3578T>C:		rs12426891	0.1086	0.0000	0/0/0	0.0975							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40661403	40661403	A	T	hom		QUAL=14657;DP=452;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+3700A>T:		rs4768224	0.6887	0.0000	0/0/0	0.6742							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				342	219					LRRK2 (inh=AD pLI=0.00)
chr12	40662039	40662039	G	A	het		QUAL=3214;DP=251;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1656+4336G>A:		rs11175793	0.1084	0.0000	0/0/0	0.0975							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40665227	40665227	G	C	hom		QUAL=8261;DP=255;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1657-3158G>C:		rs7308193	0.6883	0.0000	0/0/0	0.6624							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	220					LRRK2 (inh=AD pLI=0.00)
chr12	40665920	40665920	C	T	het		QUAL=2903;DP=220;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1657-2465C>T:	MER45A	rs73108339	0.0196	0.0000	0/0/0	0.0442							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	16					LRRK2 (inh=AD pLI=0.00)
chr12	40666805	40666806	AC	-	het		QUAL=4084;DP=426;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1657-1580_1657-1579delAC:		rs76660489	0.0609	0.0000	0/0/0	0.0709							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40666875	40666875	C	G	het		QUAL=5441;DP=448;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon14/50:c.1657-1510C>G:	MIRb	rs10878299	0.1076	0.0000	0/0/0	0.0970							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40669826	40669826	T	A	het		QUAL=3352;DP=206;AF=0.58;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon16/50:c.1941+1031T>A:	MIRc	rs10878302	0.1086	0.0000	0/0/0	0.0803							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40669939	40669939	T	C	het		QUAL=3240;DP=290;AF=0.44;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon16/50:c.1941+1144T>C:	L4_A_Mam	rs11564129	0.0431	0.0000	0/0/0	0.0734							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	13					LRRK2 (inh=AD pLI=0.00)
chr12	40670394	40670394	G	A	het		QUAL=4213;DP=287;AF=0.56;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon16/50:c.1942-1296G>A:	AluSz	rs7971935	0.0523	0.0000	0/0/0	0.0779							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40670870	40670870	T	C	het		QUAL=2833;DP=215;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon16/50:c.1942-820T>C:	AluJb	rs10784485	0.1078	0.0000	0/0/0	0.0847							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40673368	40673368	G	A	hom		QUAL=7526;DP=226;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2241+1305G>A:		rs7134572	0.8311	0.0000	0/0/0	0.8335							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				448	135					LRRK2 (inh=AD pLI=0.00)
chr12	40674423	40674423	-	TAAAATAAAA	het		QUAL=456;DP=77;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2241+2394_2241+2403dupAATAAAATAA:	AluJb	rs57373855	0.0000	0.0000	0/0/0	0.0059							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				38	110					LRRK2 (inh=AD pLI=0.00)
chr12	40674594	40674594	T	C	hom		QUAL=1817;DP=68;AF=1.00;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2241+2531T>C:	AluY	rs7488873	0.6889	0.0000	0/0/0	0.5648							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	217					LRRK2 (inh=AD pLI=0.00)
chr12	40674870	40674870	A	-	het		QUAL=3291;DP=541;AF=0.38;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-2794delA:	AluY		0.0000	0.0000	0/0/0	0.0137							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	165					LRRK2 (inh=AD pLI=0.00)
chr12	40675608	40675608	A	G	hom		QUAL=8998;DP=291;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-2069A>G:		rs7979341	0.6833	0.0000	0/0/0	0.6241							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				342	218					LRRK2 (inh=AD pLI=0.00)
chr12	40675852	40675891	CTTCCCTTCCCTTCCCTTCCCTTCCCTTCCCTTCCCTTCT	-	het		QUAL=178;DP=94;AF=0.49;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-1818_2242-1779delTCCCTTCCCTTCCCTTCCCTTCCCTTCCCTTCTCTTCCCT:	(TTCCC)n		0.0000	0.0000	0/0/0	0.0000							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	0					LRRK2 (inh=AD pLI=0.00)
chr12	40675894	40675894	T	C	het		QUAL=799;DP=112;AF=0.42;MQM=58	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-1783T>C:	(TTCCC)n		0.0000	0.0000	0/0/0	0.0022							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	48					LRRK2 (inh=AD pLI=0.00)
chr12	40675915	40675919	CCCTC	-	hom		QUAL=411;DP=31;AF=0.94;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-1735_2242-1731delCTCCC:	(TTCCC)n		0.0000	0.0000	0/0/0	0.0000							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	1					LRRK2 (inh=AD pLI=0.00)
chr12	40676847	40676847	A	-	het		QUAL=3046;DP=107;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-823delA:	MIRb	rs112859457	0.0956	0.0000	0/0/0	0.0793							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40676847	40676847	A	T	het		QUAL=3046;DP=107;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-830A>T:	MIRb	rs17466080	0.0575	0.0000	0/0/0	0.0761							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	29					LRRK2 (inh=AD pLI=0.00)
chr12	40677008	40677008	G	A	het		QUAL=4251;DP=402;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-669G>A:		rs11175852	0.1098	0.0000	0/0/0	0.0975							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				4	54					LRRK2 (inh=AD pLI=0.00)
chr12	40677029	40677029	A	C	hom		QUAL=13750;DP=421;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-648A>C:		rs10784486	0.6835	0.0000	0/0/0	0.6657							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	218					LRRK2 (inh=AD pLI=0.00)
chr12	40677584	40677584	G	T	het		QUAL=4594;DP=365;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon18/50:c.2242-93G>T:		rs73108368	0.0609	0.0000	0/0/0	0.0159							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40678064	40678065	TT	-	het		QUAL=3035;DP=168;AF=0.19;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2500+141_2500+142delTT:			0.0000	0.0000	0/0/0	0.0005							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	38					LRRK2 (inh=AD pLI=0.00)
chr12	40678064	40678064	T	-	het		QUAL=3035;DP=168;AF=0.65;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2500+142delT:		rs545506400	0.5799	0.0000	0/0/0	0.1506							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				2	477					LRRK2 (inh=AD pLI=0.00)
chr12	40679871	40679871	A	G	hom		QUAL=9499;DP=300;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2501-1282A>G:		rs4310676	0.6839	0.0000	0/0/0	0.6659							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	218					LRRK2 (inh=AD pLI=0.00)
chr12	40680814	40680814	T	C	hom		QUAL=8384;DP=262;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2501-339T>C:	MIRb	rs7955967	0.9850	0.0000	0/0/0	0.8929							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				560	31					LRRK2 (inh=AD pLI=0.00)
chr12	40680917	40680917	T	C	het		QUAL=2510;DP=209;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2501-236T>C:		rs11564150	0.0889	0.0000	0/0/0	0.0879							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40680941	40680941	A	G	het		QUAL=2365;DP=190;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2501-212A>G:		rs4318033	0.0964	0.0000	0/0/0	0.0936							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40681057	40681057	C	T	hom		QUAL=6154;DP=186;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon19/50:c.2501-96C>T:		rs4473003	0.8243	0.0000	0/0/0	0.1638							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				448	135					LRRK2 (inh=AD pLI=0.00)
chr12	40681352	40681352	-	A	het		QUAL=4161;DP=370;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2689+20dupA:		rs532723771;rs66810434	0.1102	0.0890	371/136/103	0.0759							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000359224.1 [likely benign]; 			7	140					LRRK2 (inh=AD pLI=0.00)
chr12	40682197	40682197	C	G	het		QUAL=2916;DP=268;AF=0.44;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2689+856C>G:	L1ME1	rs17519881	0.1176	0.0000	0/0/0	0.0910							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40682590	40682590	G	T	het		QUAL=3650;DP=268;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2689+1249G>T:	L1ME1	rs17466178	0.0855	0.0000	0/0/0	0.0844							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40683136	40683136	A	G	het		QUAL=2683;DP=197;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2689+1795A>G:	L1ME1	rs73102733	0.0054	0.0000	0/0/0	0.0100							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	1					LRRK2 (inh=AD pLI=0.00)
chr12	40684622	40684622	T	G	het		QUAL=3096;DP=266;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-2725T>G:	L1ME1	rs17466185	0.0988	0.0000	0/0/0	0.0883							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40684880	40684880	A	C	het		QUAL=1072;DP=106;AF=0.45;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-2467A>C:	L1PA5	rs11175902	0.0613	0.0000	0/0/0	0.0609							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40685160	40685160	G	A	hom	low_DP	QUAL=401;DP=15;AF=1.00;MQM=58	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-2187G>A:	L1PA5	rs7953822	0.9890	0.0000	0/0/0	0.7934							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				589	0					LRRK2 (inh=AD pLI=0.00)
chr12	40685233	40685233	-	ATATATAT	het	low_QUAL	QUAL=24;DP=35;AF=0.26;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-2102_2690-2095dupTATATATA:	L1PA5	rs58027627	0.0000	0.0000	0/0/0	0.0001							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	9					LRRK2 (inh=AD pLI=0.00)
chr12	40685846	40685846	C	T	het		QUAL=3462;DP=307;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-1501C>T:		rs56325408	0.0643	0.0000	0/0/0	0.0837							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40687035	40687035	C	T	het		QUAL=4988;DP=418;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon20/50:c.2690-312C>T:	L2a	rs11175913	0.0958	0.0000	0/0/0	0.0935							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40687654	40687654	A	G	hom		QUAL=6154;DP=210;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon21/50:c.2808+189A>G:		rs4483664	0.6829	0.0000	0/0/0	0.6358							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	218					LRRK2 (inh=AD pLI=0.00)
chr12	40687698	40687698	C	TAT	hom		QUAL=667;DP=76;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon21/50:c.2808+233delCinsTAT:			0.0000	0.0000	0/0/0	0.0000							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	0					LRRK2 (inh=AD pLI=0.00)
chr12	40687935	40687946	ATCTATCTATCT	-	het		QUAL=1901;DP=109;AF=0.56;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon21/50:c.2808+505_2808+516delTATCTATCTATC:	(ATCT)n	rs139565575;rs869280149	0.0000	0.0000	0/0/0	0.1469							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				20	158					LRRK2 (inh=AD pLI=0.00)
chr12	40687935	40687942	ATCTATCT	-	het		QUAL=1901;DP=109;AF=0.56;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon21/50:c.2808+509_2808+516delTATCTATC:	(ATCT)n	rs150276517	0.0000	0.0000	0/0/0	0.0329							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				13	117					LRRK2 (inh=AD pLI=0.00)
chr12	40688921	40688921	A	G	het		QUAL=3801;DP=334;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon22/50:c.2878+205A>G:		rs12314692	0.0954	0.0000	0/0/0	0.0935							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40689889	40689889	T	C	het		QUAL=3997;DP=323;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon23/50:c.3096+443T>C:	MIR3	rs73102746	0.0859	0.0000	0/0/0	0.0850							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40689982	40689982	T	C	het		QUAL=3753;DP=288;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon23/50:c.3096+536T>C:		rs10784497	0.0962	0.0000	0/0/0	0.0940							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40690706	40690706	C	A	hom		QUAL=11043;DP=344;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon23/50:c.3096+1260C>A:	L2a	rs7957057	0.6877	0.0000	0/0/0	0.6675							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				342	217					LRRK2 (inh=AD pLI=0.00)
chr12	40690870	40690871	TT	-	het		QUAL=3816;DP=407;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon23/50:c.3097-1174_3097-1173delTT:	L2a	rs76607433	0.0958	0.0000	0/0/0	0.0825							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	56					LRRK2 (inh=AD pLI=0.00)
chr12	40690944	40690944	G	A	het		QUAL=4543;DP=388;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon23/50:c.3097-1101G>A:	L2a	rs28365224	0.0613	0.0000	0/0/0	0.0840							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40692600	40692600	-	ATAA	het	low_DP	QUAL=166;DP=17;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon24/50:c.3347+306_3347+307insTAAA:	(AT)n	rs536447131	0.0519	0.0000	0/0/0	0.0184							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				2	18					LRRK2 (inh=AD pLI=0.00)
chr12	40692663	40692689	TATTATATATATACTATATATAATACT	-	het	low_DP	QUAL=307;DP=15;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon24/50:c.3348-208_3348-182delCTATATATAATACTTATTATATATATA:	(AT)n	rs199798116	0.0000	0.0000	0/0/0	0.0430							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	359					LRRK2 (inh=AD pLI=0.00)
chr12	40693225	40693225	A	C	het		QUAL=4656;DP=389;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon25/50:c.3496+166A>C:	L1MC2	rs10878336	0.1110	0.0000	0/0/0	0.0985							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40694399	40694399	G	A	het		QUAL=5388;DP=483;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon25/50:c.3496+1340G>A:		rs11175941	0.0637	0.0000	0/0/0	0.0877							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	56					LRRK2 (inh=AD pLI=0.00)
chr12	40695095	40695095	G	A	het		QUAL=1955;DP=125;AF=0.59;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon25/50:c.3497-1496G>A:	AluSc5	rs10878340	0.4950	0.0000	0/0/0	0.5122							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				180	284					LRRK2 (inh=AD pLI=0.00)
chr12	40695851	40695851	C	G	hom		QUAL=1539;DP=51;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon25/50:c.3497-740C>G:	AluSc8	rs7312696	0.9870	0.0000	0/0/0	0.8845							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				566	24					LRRK2 (inh=AD pLI=0.00)
chr12	40697434	40697434	G	A	hom		QUAL=5301;DP=158;AF=1.00;MQM=60	LRRK2	sequence_feature,intron	LRRK2:NM_198578.3:sequence_feature:LOW::c.3591-316G>A:,LRRK2:NM_198578.3:intron:MODIFIER:exon26/50:c.3591-316G>A:	MIR	rs10784498	0.4020	0.0000	0/0/0	0.3621							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				88	263					LRRK2 (inh=AD pLI=0.00)
chr12	40697477	40697477	C	T	hom		QUAL=6108;DP=194;AF=0.99;MQM=60	LRRK2	sequence_feature,intron	LRRK2:NM_198578.3:sequence_feature:LOW::c.3591-273C>T:,LRRK2:NM_198578.3:intron:MODIFIER:exon26/50:c.3591-273C>T:	MIR	rs10878341	0.3758	0.0000	0/0/0	0.3533							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				88	263					LRRK2 (inh=AD pLI=0.00)
chr12	40698490	40698490	C	T	hom		QUAL=5797;DP=178;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon27/50:c.3777+554C>T:		rs10784499	0.3620	0.0000	0/0/0	0.0642							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				89	280					LRRK2 (inh=AD pLI=0.00)
chr12	40700106	40700107	TT	-	het		QUAL=2387;DP=229;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3959+338_3959+339delTT:		rs146071397	0.0481	0.0000	0/0/0	0.0742							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40701271	40701271	G	T	het		QUAL=2126;DP=171;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3960-998G>T:		rs11564180	0.0986	0.0000	0/0/0	0.0859							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40701583	40701583	-	T	het		QUAL=108;DP=116;AF=0.22;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3960-669dupT:	AluSg4	rs201473630;rs71434314	0.5653	0.0000	0/0/0	0.2955							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	11					LRRK2 (inh=AD pLI=0.00)
chr12	40701729	40701729	A	G	het		QUAL=911;DP=89;AF=0.51;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3960-540A>G:	AluSg4	rs11175959	0.0000	0.0000	0/0/0	0.0335							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40701831	40701831	C	T	het		QUAL=2299;DP=199;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3960-438C>T:	AluSg4	rs113772607	0.0986	0.0000	0/0/0	0.0864							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40702164	40702164	C	T	het		QUAL=1643;DP=165;AF=0.41;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon28/50:c.3960-105C>T:		rs11564149	0.0986	0.0000	0/0/0	0.0177							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40702771	40702771	C	T	het		QUAL=1709;DP=171;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon29/50:c.4190-137C>T:		rs11175963	0.0609	0.0000	0/0/0	0.0160							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40702846	40702846	A	T	hom		QUAL=7909;DP=240;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon29/50:c.4190-62A>T:		rs7305344	0.6825	0.0000	0/0/0	0.5463							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				576	470					LRRK2 (inh=AD pLI=0.00)
chr12	40702911	40702911	G	A	het	pred_pathogenic	QUAL=2861;DP=263;AF=0.43;MQM=60	LRRK2	missense,sequence_feature	LRRK2:NM_198578.3:missense:MODERATE:exon30/51:c.4193G>A:p.Arg1398His,LRRK2:NM_198578.3:sequence_feature:LOW:exon30/51:c.4193G>A:		rs7133914	0.1004	0.0841	520/223/102	0.0851	3.2530	T	T	P,P	T	23.10	609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032452.2 [other]; 	CM104617 [CLASS=DFP MUT=ALT PHEN="Parkinson disease reduced risk association with" GENE=LRRK2]; 		9	246	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40702987	40702987	G	A	het		QUAL=2877;DP=283;AF=0.41;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon30/51:c.4269G>A:p.Lys1423Lys		rs11175964	0.0609	0.0721	395/213/3	0.0733							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032455.2 [other]; 			7	245	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40703087	40703087	-	GT	hom		QUAL=3591;DP=154;AF=0.81;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon30/50:c.4317+69_4317+70dupGT:	(TG)n	rs10650388;rs397805328;rs66990153	0.0000	0.5069	3349/1494/533	0.4019							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				241	591					LRRK2 (inh=AD pLI=0.00)
chr12	40703865	40703865	A	G	het		QUAL=2274;DP=212;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon30/50:c.4318-368A>G:		rs10784501	0.5849	0.0000	0/0/0	0.5615							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				313	241					LRRK2 (inh=AD pLI=0.00)
chr12	40704557	40704557	T	C	het		QUAL=3939;DP=298;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4536+106T>C:		rs41286474	0.0847	0.0000	0/0/0	0.0172							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40705149	40705149	T	-	hom		QUAL=7597;DP=239;AF=0.97;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4536+707delT:		rs34073574;rs869212703	0.6831	0.0000	0/0/0	0.3218							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				348	212					LRRK2 (inh=AD pLI=0.00)
chr12	40705158	40705158	T	A	hom		QUAL=7597;DP=239;AF=0.97;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4536+707T>A:		rs2069228	0.6831	0.0000	0/0/0	0.2497							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				347	213					LRRK2 (inh=AD pLI=0.00)
chr12	40705700	40705700	C	G	het		QUAL=2714;DP=205;AF=0.53;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4536+1249C>G:	MARNA	rs10784503	0.5857	0.0000	0/0/0	0.5205							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40705766	40705766	-	T	het		QUAL=1750;DP=186;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4536+1325dupT:	MARNA	rs370305841	0.5711	0.0000	0/0/0	0.3633							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				60	494					LRRK2 (inh=AD pLI=0.00)
chr12	40706375	40706375	G	T	hom		QUAL=10468;DP=325;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-1399G>T:		rs2896975	0.6833	0.0000	0/0/0	0.6518							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				349	212					LRRK2 (inh=AD pLI=0.00)
chr12	40706531	40706531	G	A	hom		QUAL=7527;DP=239;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-1243G>A:		rs7302503	0.6831	0.0000	0/0/0	0.6526							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				358	232					LRRK2 (inh=AD pLI=0.00)
chr12	40706604	40706604	T	C	het		QUAL=3478;DP=290;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-1170T>C:		rs7137160	0.5857	0.0000	0/0/0	0.5611							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				329	254					LRRK2 (inh=AD pLI=0.00)
chr12	40706741	40706747	TAAGAGA	-	het		QUAL=2586;DP=242;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-1031_4537-1025delAGAGATA:		rs369794148	0.0849	0.0000	0/0/0	0.0839							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	27					LRRK2 (inh=AD pLI=0.00)
chr12	40706793	40706793	A	-	het		QUAL=3470;DP=272;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-980delA:		rs796649577	0.5857	0.0000	0/0/0	0.5186							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40707201	40707201	A	G	het		QUAL=2953;DP=229;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-573A>G:		rs10467144	0.5855	0.0000	0/0/0	0.5433							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40707396	40707396	T	G	het		QUAL=2022;DP=154;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon31/50:c.4537-378T>G:		rs10784504	0.5855	0.0000	0/0/0	0.5403							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				324	229					LRRK2 (inh=AD pLI=0.00)
chr12	40708892	40708892	T	C	hom		QUAL=10988;DP=343;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon32/50:c.4739-122T>C:	MIR3	rs1427267	0.6829	0.0000	0/0/0	0.6498							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				349	212					LRRK2 (inh=AD pLI=0.00)
chr12	40708922	40708922	C	T	het		QUAL=4802;DP=387;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon32/50:c.4739-92C>T:	MIR3	rs1427266	0.5857	0.0000	0/0/0	0.1084							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				326	230					LRRK2 (inh=AD pLI=0.00)
chr12	40709185	40709185	A	G	het		QUAL=5363;DP=377;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+83A>G:		rs721713	0.5857	0.0000	0/0/0	0.1118							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				387	296					LRRK2 (inh=AD pLI=0.00)
chr12	40709318	40709318	G	A	het		QUAL=5216;DP=419;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+216G>A:		rs721712	0.5857	0.0000	0/0/0	0.5611							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	231					LRRK2 (inh=AD pLI=0.00)
chr12	40709328	40709328	G	A	het		QUAL=5282;DP=450;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+226G>A:		rs721711	0.5857	0.0000	0/0/0	0.5609							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40709413	40709413	T	A	hom		QUAL=16861;DP=510;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+311T>A:		rs721709	0.6829	0.0000	0/0/0	0.6526							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				348	212					LRRK2 (inh=AD pLI=0.00)
chr12	40709499	40709499	T	G	het		QUAL=4513;DP=414;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+397T>G:		rs4768227	0.5857	0.0000	0/0/0	0.5615							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40709609	40709609	T	-	hom		QUAL=9881;DP=313;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+513delT:		rs398098159	0.6831	0.0000	0/0/0	0.6054							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				348	213					LRRK2 (inh=AD pLI=0.00)
chr12	40709624	40709624	G	T	het		QUAL=4082;DP=369;AF=0.43;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+522G>T:		rs4767969	0.5857	0.0000	0/0/0	0.5565							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	231					LRRK2 (inh=AD pLI=0.00)
chr12	40711046	40711046	C	T	het		QUAL=1147;DP=136;AF=0.37;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+1944C>T:		rs10748029	0.5857	0.0000	0/0/0	0.5348							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	227					LRRK2 (inh=AD pLI=0.00)
chr12	40711070	40711070	C	T	het		QUAL=1012;DP=139;AF=0.35;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+1968C>T:		rs10784506	0.5853	0.0000	0/0/0	0.5309							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	226					LRRK2 (inh=AD pLI=0.00)
chr12	40711091	40711091	G	A	het		QUAL=1490;DP=168;AF=0.37;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+1989G>A:		rs10878358	0.5849	0.0000	0/0/0	0.5404							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	227					LRRK2 (inh=AD pLI=0.00)
chr12	40711094	40711094	A	T	het		QUAL=2964;DP=168;AF=0.63;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4827+1992A>T:		rs7132073	0.0978	0.0000	0/0/0	0.0875							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40711998	40711998	C	A	het		QUAL=7462;DP=507;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-1792C>A:	MLT1H2	rs1427265	0.5857	0.0000	0/0/0	0.5613							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				327	229					LRRK2 (inh=AD pLI=0.00)
chr12	40712193	40712193	G	A	het		QUAL=4078;DP=309;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-1597G>A:		rs1427264	0.5857	0.0000	0/0/0	0.5601							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				326	229					LRRK2 (inh=AD pLI=0.00)
chr12	40712575	40712575	A	C	het		QUAL=1706;DP=211;AF=0.36;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-1215A>C:		rs2114569	0.5857	0.0000	0/0/0	0.5598							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40712620	40712620	G	A	het		QUAL=2217;DP=266;AF=0.35;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-1170G>A:		rs2114568	0.5857	0.0000	0/0/0	0.5609							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40713003	40713003	G	A	het		QUAL=1815;DP=132;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-787G>A:	MIR	rs2162469	0.5857	0.0000	0/0/0	0.5615							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40713200	40713200	G	A	het		QUAL=4809;DP=381;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-590G>A:	MER5A1	rs10784509	0.5859	0.0000	0/0/0	0.5616							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40713560	40713560	T	G	het		QUAL=4121;DP=339;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-230T>G:		rs1896254	0.5861	0.0000	0/0/0	0.5507							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				324	231					LRRK2 (inh=AD pLI=0.00)
chr12	40713587	40713587	A	-	het		QUAL=3922;DP=259;AF=0.58;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-202delA:		rs5797667	0.5857	0.0000	0/0/0	0.4822							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				312	243					LRRK2 (inh=AD pLI=0.00)
chr12	40713595	40713595	T	C	het		QUAL=3879;DP=324;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-195T>C:		rs1896253	0.5857	0.0000	0/0/0	0.3030							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				282	273					LRRK2 (inh=AD pLI=0.00)
chr12	40713759	40713759	T	C	het		QUAL=4361;DP=327;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon33/50:c.4828-31T>C:		rs1896252	0.5857	0.5734	20012/9763/1664	0.5555							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				507	501					LRRK2 (inh=AD pLI=0.00)
chr12	40713834	40713834	C	A	hom		QUAL=11183;DP=347;AF=0.99;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon34/51:c.4872C>A:p.Gly1624Gly		rs1427263	0.6829	0.6781	28109/14376/2983	0.6662							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032471.2 [other]; 		COSM3753217, COSM3753216	1118	988	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40713873	40713873	A	G	het		QUAL=3762;DP=339;AF=0.43;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon34/51:c.4911A>G:p.Lys1637Lys		rs11176013	0.5857	0.5734	20178/9812/1755	0.5483							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032473.2 [other]; 		COSM289938, COSM289939	883	1063	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40714188	40714188	G	A	het		QUAL=1944;DP=149;AF=0.49;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5015+211G>A:		rs10748030	0.5857	0.0000	0/0/0	0.5518							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				324	231					LRRK2 (inh=AD pLI=0.00)
chr12	40714266	40714266	T	C	het		QUAL=3667;DP=259;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5015+289T>C:	(TG)n	rs10748031	0.5847	0.0000	0/0/0	0.3709							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40714267	40714267	G	T	het		QUAL=3667;DP=259;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5015+290G>T:	(TG)n	rs10748032	0.5857	0.0000	0/0/0	0.3753							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40714395	40714395	C	T	het		QUAL=2788;DP=255;AF=0.44;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5015+418C>T:		rs10748033	0.5857	0.0000	0/0/0	0.5546							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40714501	40714501	T	G	het		QUAL=3852;DP=259;AF=0.53;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5016-335T>G:		rs10735931	0.5855	0.0000	0/0/0	0.5561							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40714618	40714618	C	T	het		QUAL=3235;DP=231;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5016-218C>T:		rs10748034	0.5857	0.0000	0/0/0	0.5604							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				323	232					LRRK2 (inh=AD pLI=0.00)
chr12	40714785	40714785	A	T	het		QUAL=4336;DP=354;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon34/50:c.5016-51A>T:		rs10878368	0.5857	0.5735	20259/9833/1789	0.5600							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				567	562					LRRK2 (inh=AD pLI=0.00)
chr12	40715013	40715013	T	A	het		QUAL=3541;DP=247;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon35/50:c.5170+23T>A:		rs7307276	0.5857	0.5756	19995/9701/1754	0.5599							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				506	497					LRRK2 (inh=AD pLI=0.00)
chr12	40715248	40715248	T	C	het		QUAL=1969;DP=223;AF=0.38;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon35/50:c.5170+258T>C:		rs4768229	0.5859	0.0000	0/0/0	0.5616							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	231					LRRK2 (inh=AD pLI=0.00)
chr12	40715310	40715310	-	A	het		QUAL=1965;DP=195;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon35/50:c.5170+327dupA:		rs869145368	0.5847	0.0000	0/0/0	0.5147							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				325	230					LRRK2 (inh=AD pLI=0.00)
chr12	40715590	40715590	C	T	het		QUAL=688;DP=64;AF=0.44;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon35/50:c.5171-247C>T:		rs4423250	0.0479	0.0000	0/0/0	0.0739							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40716015	40716015	C	T	hom		QUAL=9961;DP=323;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon36/50:c.5317+32C>T:		rs7137665	0.6833	0.6788	27752/14119/2985	0.6648							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				672	529					LRRK2 (inh=AD pLI=0.00)
chr12	40716038	40716038	A	-	het		QUAL=2104;DP=271;AF=0.35;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon36/50:c.5317+68delA:		rs66762941	0.0000	0.0000	0/0/0	0.0044							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				2	134					LRRK2 (inh=AD pLI=0.00)
chr12	40716260	40716260	T	C	het		QUAL=4589;DP=411;AF=0.44;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon37/51:c.5457T>C:p.Gly1819Gly		rs10878371	0.5853	0.5733	20261/9840/1779	0.5614							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032483.2 [other]; 			883	1072	1	[1] old entry - no details available			LRRK2 (inh=AD pLI=0.00)
chr12	40716474	40716474	T	C	het		QUAL=2787;DP=207;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon37/50:c.5509+162T>C:		rs11176022	0.0609	0.0000	0/0/0	0.0825							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40717601	40717603	TTT	-	het		QUAL=2714;DP=165;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5656+506_5656+508delTTT:		rs398055492;rs76080191	0.0000	0.0000	0/0/0	0.0536							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	157					LRRK2 (inh=AD pLI=0.00)
chr12	40717601	40717602	TT	-	het		QUAL=2714;DP=165;AF=0.34;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5656+507_5656+508delTT:		rs761931834	0.6342	0.0000	0/0/0	0.3407							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				76	355					LRRK2 (inh=AD pLI=0.00)
chr12	40718883	40718883	T	C	het		QUAL=1386;DP=127;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5656+1775T>C:	AluSg7	rs3747891	0.1000	0.0000	0/0/0	0.0835							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40719500	40719500	A	C	het		QUAL=5078;DP=446;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5656+2392A>C:		rs7298930	0.5857	0.0000	0/0/0	0.5616							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				326	229					LRRK2 (inh=AD pLI=0.00)
chr12	40719806	40719806	G	C	het		QUAL=6007;DP=510;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5657-2356G>C:	MamTip2	rs17444089	0.0481	0.0000	0/0/0	0.0743							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40720004	40720004	T	C	hom		QUAL=5832;DP=190;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5657-2158T>C:	AluY	rs10878377	0.6839	0.0000	0/0/0	0.6083							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				351	210					LRRK2 (inh=AD pLI=0.00)
chr12	40720279	40720279	-	A	het		QUAL=1111;DP=493;AF=0.21;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5657-1872dupA:	AluY	rs561546782	0.0000	0.0000	0/0/0	0.0242							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	32					LRRK2 (inh=AD pLI=0.00)
chr12	40720299	40720299	A	C	het		QUAL=2965;DP=517;AF=0.33;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon38/50:c.5657-1863A>C:		rs12316801	0.1048	0.0000	0/0/0	0.0883							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	61					LRRK2 (inh=AD pLI=0.00)
chr12	40722452	40722452	A	G	hom		QUAL=7049;DP=220;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+190A>G:		rs2404832	0.3934	0.0000	0/0/0	0.3595							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				69	255					LRRK2 (inh=AD pLI=0.00)
chr12	40722457	40722457	G	A	hom		QUAL=7504;DP=228;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+195G>A:		rs2404833	0.9880	0.0000	0/0/0	0.8945							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				569	24					LRRK2 (inh=AD pLI=0.00)
chr12	40722549	40722549	C	A	het		QUAL=2730;DP=237;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+287C>A:	MER5A1	rs17466486	0.0974	0.0000	0/0/0	0.0850							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40723475	40723475	T	A	het		QUAL=1197;DP=120;AF=0.41;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+1213T>A:		rs10506152	0.0841	0.0000	0/0/0	0.0798							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	26					LRRK2 (inh=AD pLI=0.00)
chr12	40723900	40723900	C	T	het		QUAL=4296;DP=340;AF=0.48;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+1638C>T:	HAL1ME	rs11176052	0.2949	0.0000	0/0/0	0.2707							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				63	240					LRRK2 (inh=AD pLI=0.00)
chr12	40724030	40724030	C	T	het		QUAL=4707;DP=350;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+1768C>T:	HAL1ME	rs11176053	0.2947	0.0000	0/0/0	0.2703							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				63	241					LRRK2 (inh=AD pLI=0.00)
chr12	40724960	40724960	G	T	het		QUAL=6593;DP=473;AF=0.52;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+2698G>T:	HAL1ME	rs7307562	0.4455	0.0000	0/0/0	0.4352							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				174	296					LRRK2 (inh=AD pLI=0.00)
chr12	40725399	40725399	-	A	het		QUAL=4799;DP=217;AF=0.80;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5757+3147dupA:	MER30	rs397736185	0.6222	0.0000	0/0/0	0.4496							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				7	538					LRRK2 (inh=AD pLI=0.00)
chr12	40725778	40725778	G	A	hom		QUAL=5417;DP=165;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-2991G>A:		rs963243	0.6775	0.0000	0/0/0	0.6498							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				315	231					LRRK2 (inh=AD pLI=0.00)
chr12	40725928	40725928	A	G	het		QUAL=2979;DP=268;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-2841A>G:		rs10878386	0.0667	0.0000	0/0/0	0.0884							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	54					LRRK2 (inh=AD pLI=0.00)
chr12	40726567	40726567	C	G	het		QUAL=4671;DP=291;AF=0.58;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-2202C>G:		rs17466521	0.2198	0.0000	0/0/0	0.2068							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				18	183					LRRK2 (inh=AD pLI=0.00)
chr12	40726762	40726762	-	AA	het		QUAL=4148;DP=413;AF=0.25;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-1995_5758-1994dupAA:		rs35031086	0.0000	0.0000	0/0/0	0.0413							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	14					LRRK2 (inh=AD pLI=0.00)
chr12	40726762	40726762	-	A	het		QUAL=4148;DP=413;AF=0.39;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-1994dupA:		rs35031086;rs398019202	0.7350	0.0000	0/0/0	0.4680							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	486					LRRK2 (inh=AD pLI=0.00)
chr12	40727924	40727924	A	G	hom		QUAL=15235;DP=461;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-845A>G:	MER117	rs2896976	0.9916	0.0000	0/0/0	0.8956							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				594	0					LRRK2 (inh=AD pLI=0.00)
chr12	40728191	40728191	C	A	hom		QUAL=16327;DP=492;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon39/50:c.5758-578C>A:	Tigger2a	rs4465428	0.8319	0.0000	0/0/0	0.8413							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				433	146					LRRK2 (inh=AD pLI=0.00)
chr12	40729007	40729007	C	T	het		QUAL=7576;DP=553;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+48C>T:		rs2404834	0.0946	0.1257	1054/676/104	0.1178							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				11	167					LRRK2 (inh=AD pLI=0.00)
chr12	40730463	40730463	C	T	hom		QUAL=11476;DP=351;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+1504C>T:		rs2404835	0.4105	0.0000	0/0/0	0.3812							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				59	254					LRRK2 (inh=AD pLI=0.00)
chr12	40730936	40730936	A	-	het		QUAL=3380;DP=248;AF=0.53;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+1978delA:		rs796836125	0.4990	0.0000	0/0/0	0.4693							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				242	275					LRRK2 (inh=AD pLI=0.00)
chr12	40731183	40731183	A	C	het		QUAL=4297;DP=322;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+2224A>C:		rs715403	0.2033	0.0000	0/0/0	0.2718							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	119					LRRK2 (inh=AD pLI=0.00)
chr12	40731214	40731214	G	A	hom		QUAL=8715;DP=273;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+2255G>A:		rs715402	0.8243	0.0000	0/0/0	0.8430							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				432	145					LRRK2 (inh=AD pLI=0.00)
chr12	40731506	40731506	G	C	het		QUAL=6020;DP=465;AF=0.49;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5948+2547G>C:		rs6581667	0.4988	0.0000	0/0/0	0.5077							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				241	276					LRRK2 (inh=AD pLI=0.00)
chr12	40731606	40731606	G	A	het		QUAL=5723;DP=478;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-2490G>A:		rs6581668	0.4992	0.0000	0/0/0	0.5078							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				241	277					LRRK2 (inh=AD pLI=0.00)
chr12	40731960	40731962	CCT	-	het		QUAL=8711;DP=304;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-2135_5949-2133delCTC:	L2c	rs200521371	0.0643	0.0000	0/0/0	0.0715							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				4	53					LRRK2 (inh=AD pLI=0.00)
chr12	40731961	40731961	C	T	het		QUAL=8711;DP=304;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-2135C>T:	L2c	rs4767970	0.6837	0.0000	0/0/0	0.4007							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				299	240					LRRK2 (inh=AD pLI=0.00)
chr12	40732032	40732032	C	T	hom		QUAL=8034;DP=248;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-2064C>T:	L2c	rs4767971	0.8061	0.0000	0/0/0	0.8376							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				435	142					LRRK2 (inh=AD pLI=0.00)
chr12	40732123	40732123	C	T	hom		QUAL=6179;DP=190;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1973C>T:	L2c	rs4767972	0.7031	0.0000	0/0/0	0.7794							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40732394	40732394	T	C	hom		QUAL=6915;DP=212;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1702T>C:		rs1427271	0.7031	0.0000	0/0/0	0.7767							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	215					LRRK2 (inh=AD pLI=0.00)
chr12	40732480	40732480	G	C	hom		QUAL=7928;DP=241;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1616G>C:		rs1427272	0.7029	0.0000	0/0/0	0.7775							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40732730	40732730	C	G	hom		QUAL=10558;DP=319;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1366C>G:		rs1427273	0.7029	0.0000	0/0/0	0.7779							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40732900	40732900	C	A	het		QUAL=4426;DP=417;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1196C>A:		rs10735934	0.4984	0.0000	0/0/0	0.5073							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				241	276					LRRK2 (inh=AD pLI=0.00)
chr12	40733082	40733082	A	G	hom		QUAL=8115;DP=258;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-1014A>G:		rs10732751	0.7031	0.0000	0/0/0	0.7799							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40733564	40733564	T	G	hom		QUAL=7176;DP=217;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon40/50:c.5949-532T>G:		rs12306060	0.7031	0.0000	0/0/0	0.7767							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	217					LRRK2 (inh=AD pLI=0.00)
chr12	40734583	40734583	T	C	hom		QUAL=10443;DP=318;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+327T>C:		rs1365763	0.7031	0.0000	0/0/0	0.7803							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40734916	40734916	C	A	hom		QUAL=12877;DP=402;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+660C>A:		rs7963697	0.7031	0.0000	0/0/0	0.7809							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	214					LRRK2 (inh=AD pLI=0.00)
chr12	40735169	40735169	G	C	hom		QUAL=12366;DP=383;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+913G>C:		rs7963086	0.8245	0.0000	0/0/0	0.8441							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				435	143					LRRK2 (inh=AD pLI=0.00)
chr12	40735764	40735764	T	C	hom		QUAL=11739;DP=369;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+1508T>C:		rs7956787	0.7031	0.0000	0/0/0	0.7796							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40735804	40735804	T	G	hom		QUAL=13539;DP=405;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+1548T>G:		rs7956898	0.7031	0.0000	0/0/0	0.7807							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40735939	40735939	G	A	het		QUAL=5464;DP=443;AF=0.49;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+1683G>A:		rs10506155	0.1911	0.0000	0/0/0	0.2694							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	120					LRRK2 (inh=AD pLI=0.00)
chr12	40736010	40736010	A	G	hom		QUAL=11907;DP=370;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+1754A>G:		rs7954061	0.7031	0.0000	0/0/0	0.7805							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40736043	40736043	T	A	hom		QUAL=12710;DP=409;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+1787T>A:		rs7957151	0.7031	0.0000	0/0/0	0.7805							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40736281	40736281	-	TT	het		QUAL=7100;DP=489;AF=0.53;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2037_6109+2038dupTT:		rs3065921;rs397837938	0.7700	0.0000	0/0/0	0.4347							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	343					LRRK2 (inh=AD pLI=0.00)
chr12	40736281	40736281	-	T	het		QUAL=7100;DP=489;AF=0.17;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2038dupT:		rs3065921	0.0000	0.0000	0/0/0	0.0164							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	244					LRRK2 (inh=AD pLI=0.00)
chr12	40736405	40736405	C	T	hom		QUAL=13512;DP=424;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2149C>T:	(ACT)n	rs919175	0.7031	0.0000	0/0/0	0.7233							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40736782	40736782	C	T	hom		QUAL=10476;DP=318;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2526C>T:	MIR	rs1035812	0.7027	0.0000	0/0/0	0.7794							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40737002	40737002	G	A	hom		QUAL=11323;DP=337;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2746G>A:		rs1365764	0.7031	0.0000	0/0/0	0.7790							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40737059	40737059	-	TCAG	hom		QUAL=10511;DP=312;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2808_6109+2811dupTCAG:		rs397724721	0.7025	0.0000	0/0/0	0.6821							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				338	217					LRRK2 (inh=AD pLI=0.00)
chr12	40737075	40737075	C	T	hom		QUAL=12580;DP=378;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2819C>T:		rs17461964	0.7029	0.0000	0/0/0	0.4920							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40737115	40737115	G	T	hom		QUAL=11214;DP=333;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2859G>T:		rs10784518	0.7031	0.0000	0/0/0	0.7802							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40737183	40737183	G	A	hom		QUAL=9797;DP=298;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2927G>A:		rs4768231	0.7031	0.0000	0/0/0	0.7797							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	214					LRRK2 (inh=AD pLI=0.00)
chr12	40737240	40737240	C	T	hom		QUAL=7490;DP=224;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6109+2984C>T:		rs4768232	0.7031	0.0000	0/0/0	0.7774							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40737803	40737803	A	G	hom		QUAL=5700;DP=191;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-2752A>G:		rs3943893	0.7029	0.0000	0/0/0	0.7756							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40737908	40737908	C	T	hom		QUAL=6483;DP=202;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-2647C>T:		rs1035813	0.7029	0.0000	0/0/0	0.7643							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40738008	40738008	C	T	het		QUAL=1950;DP=182;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-2547C>T:	L3	rs10459264	0.0645	0.0000	0/0/0	0.0877							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	54					LRRK2 (inh=AD pLI=0.00)
chr12	40738303	40738303	G	A	het		QUAL=5187;DP=412;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-2252G>A:	MIRc	rs10459265	0.4856	0.0000	0/0/0	0.5029							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				240	277					LRRK2 (inh=AD pLI=0.00)
chr12	40739421	40739421	T	A	het		QUAL=3805;DP=229;AF=0.68;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-1134T>A:	AluSx1	rs11832935	0.4856	0.0000	0/0/0	0.4466							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				242	274					LRRK2 (inh=AD pLI=0.00)
chr12	40739436	40739436	-	G	het		QUAL=1624;DP=243;AF=0.36;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-1119_6110-1118insG:	AluSx1	rs199940714	0.0000	0.0000	0/0/0	0.0267							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	5					LRRK2 (inh=AD pLI=0.00)
chr12	40739727	40739727	C	T	hom		QUAL=8681;DP=260;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-828C>T:		rs7296657	0.7029	0.0000	0/0/0	0.7765							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40739852	40739852	A	T	hom		QUAL=6721;DP=215;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-703A>T:		rs7312497	0.7029	0.0000	0/0/0	0.7697							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40739990	40739990	T	-	hom		QUAL=9783;DP=343;AF=0.95;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon41/50:c.6110-556delT:	(T)n	rs10715758	0.7033	0.0000	0/0/0	0.5517							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40740829	40740829	T	-	hom		QUAL=4195;DP=152;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6280+111delT:		rs796827140	0.7021	0.0000	0/0/0	0.6511							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	213					LRRK2 (inh=AD pLI=0.00)
chr12	40740835	40740835	T	G	het		QUAL=4195;DP=152;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6280+110T>G:		rs74467833	0.2039	0.0000	0/0/0	0.0804							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	118					LRRK2 (inh=AD pLI=0.00)
chr12	40740947	40740947	A	G	hom		QUAL=5007;DP=154;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6280+222A>G:		rs7131694	0.8323	0.0000	0/0/0	0.8367							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				434	142					LRRK2 (inh=AD pLI=0.00)
chr12	40741758	40741758	-	AA	het		QUAL=3392;DP=173;AF=0.38;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-443_6281-442dupAA:	AluSz	rs55907973	0.4962	0.0000	0/0/0	0.3062							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				207	284					LRRK2 (inh=AD pLI=0.00)
chr12	40741758	40741758	-	A	het		QUAL=3392;DP=173;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-442dupA:	AluSz	rs55907973	0.2043	0.0000	0/0/0	0.1653							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	143					LRRK2 (inh=AD pLI=0.00)
chr12	40741821	40741821	A	G	hom		QUAL=6593;DP=210;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-390A>G:		rs1365765	0.7029	0.0000	0/0/0	0.7720							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40742005	40742006	TA	C	het		QUAL=3398;DP=122;AF=0.55;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-206_6281-205delTAinsC:	EUTREP4	rs796721189	0.0000	0.0000	0/0/0	0.0771							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	0					LRRK2 (inh=AD pLI=0.00)
chr12	40742005	40742005	T	C	het		QUAL=3398;DP=122;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-206T>C:	EUTREP4	rs2896977	0.2322	0.0000	0/0/0	0.1350							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	119					LRRK2 (inh=AD pLI=0.00)
chr12	40742073	40742073	C	T	hom		QUAL=3667;DP=112;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon42/50:c.6281-138C>T:		rs1365766	0.7029	0.0000	0/0/0	0.1599							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	213					LRRK2 (inh=AD pLI=0.00)
chr12	40742689	40742689	T	C	hom		QUAL=11739;DP=355;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+378T>C:	L1MEg	rs7294958	0.7031	0.0000	0/0/0	0.7228							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40742701	40742701	C	T	het		QUAL=4550;DP=319;AF=0.52;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+390C>T:	L1MEg	rs61915610	0.2047	0.0000	0/0/0	0.2510							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	119					LRRK2 (inh=AD pLI=0.00)
chr12	40742876	40742876	A	T	hom		QUAL=8090;DP=247;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+565A>T:	L1MEg	rs7294952	0.7031	0.0000	0/0/0	0.7649							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40743312	40743314	TTC	-	hom		QUAL=4583;DP=161;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+1003_6381+1005delCTT:	AluJr	rs145677990	0.7025	0.0000	0/0/0	0.6950							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	213					LRRK2 (inh=AD pLI=0.00)
chr12	40743361	40743368	GCTGGAGT	-	hom		QUAL=4351;DP=168;AF=0.96;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+1060_6381+1067delTGGAGTGC:	AluJr	rs764747510	0.7031	0.0000	0/0/0	0.7161							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	211					LRRK2 (inh=AD pLI=0.00)
chr12	40743492	40743492	-	T	het		QUAL=4008;DP=379;AF=0.49;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+1188dupT:	AluJr	rs397964698	0.2045	0.0000	0/0/0	0.2519							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	120					LRRK2 (inh=AD pLI=0.00)
chr12	40743788	40743788	C	T	hom		QUAL=19902;DP=608;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6381+1477C>T:	L1MEg	rs4768233	0.7033	0.0000	0/0/0	0.7803							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40743830	40743830	G	A	hom		QUAL=19657;DP=594;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-1511G>A:	L1MEg	rs4768234	0.7027	0.0000	0/0/0	0.7803							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40744086	40744086	A	T	hom		QUAL=13002;DP=389;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-1255A>T:	L1MEg	rs4768235	0.7031	0.0000	0/0/0	0.7789							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40744145	40744145	C	A	hom		QUAL=11781;DP=359;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-1196C>A:	L1MEg	rs7314455	0.7031	0.0000	0/0/0	0.7800							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40744183	40744183	G	A	hom		QUAL=11591;DP=345;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-1158G>A:	L1MEg	rs7313525	0.7031	0.0000	0/0/0	0.7804							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40744394	40744394	G	T	hom		QUAL=4626;DP=137;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-947G>T:		rs7313895	0.7031	0.0000	0/0/0	0.7753							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40744491	40744491	C	T	hom		QUAL=4406;DP=133;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-850C>T:		rs7314863	0.7031	0.0000	0/0/0	0.7470							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	215					LRRK2 (inh=AD pLI=0.00)
chr12	40744808	40744808	G	A	het		QUAL=1923;DP=140;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-533G>A:	MIRc	rs7132187	0.2047	0.0000	0/0/0	0.2720							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	119					LRRK2 (inh=AD pLI=0.00)
chr12	40745181	40745181	T	C	hom		QUAL=11547;DP=346;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon43/50:c.6382-160T>C:		rs7307310	0.8241	0.0000	0/0/0	0.8435							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				435	143					LRRK2 (inh=AD pLI=0.00)
chr12	40745902	40745902	G	C	het		QUAL=3585;DP=308;AF=0.45;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+367G>C:	LTR16A1	rs11176154	0.2047	0.0000	0/0/0	0.2723							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	118					LRRK2 (inh=AD pLI=0.00)
chr12	40745914	40745914	T	C	hom		QUAL=9674;DP=306;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+379T>C:	LTR16A1	rs7311247	0.7033	0.0000	0/0/0	0.7793							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40745955	40745955	C	T	hom		QUAL=10913;DP=339;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+420C>T:	LTR16A1	rs7137437	0.7031	0.0000	0/0/0	0.7796							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40746038	40746038	G	-	het		QUAL=3730;DP=328;AF=0.47;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+505delG:	LTR16A1	rs75439407	0.2047	0.0000	0/0/0	0.2532							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				6	122					LRRK2 (inh=AD pLI=0.00)
chr12	40746073	40746073	T	C	het		QUAL=4243;DP=316;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+538T>C:	LTR16A1	rs73107108	0.0563	0.0000	0/0/0	0.0968							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	28					LRRK2 (inh=AD pLI=0.00)
chr12	40746271	40746271	-	TTTTTTTTTTTTTT	hom		QUAL=297;DP=82;AF=0.18;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+746_6576+747insTTTTTTTTTTTTTT:			0.0000	0.0000	0/0/0	0.0008							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	4					LRRK2 (inh=AD pLI=0.00)
chr12	40746455	40746455	A	G	hom	low_MQM	QUAL=607;DP=23;AF=1.00;MQM=38	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+920A>G:	SVA_C	rs11176155	0.7029	0.0000	0/0/0	0.4128							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				328	207					LRRK2 (inh=AD pLI=0.00)
chr12	40746509	40746509	T	G	hom	low_MQM	QUAL=559;DP=21;AF=1.00;MQM=38	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+974T>G:	SVA_C	rs10878409	0.0000	0.0000	0/0/0	0.2587							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				317	219					LRRK2 (inh=AD pLI=0.00)
chr12	40746676	40746676	C	T	hom		QUAL=2586;DP=82;AF=1.00;MQM=54	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+1141C>T:	SVA_C	rs10878410	0.7029	0.0000	0/0/0	0.2217							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				337	217					LRRK2 (inh=AD pLI=0.00)
chr12	40746729	40746729	G	C	het		QUAL=749;DP=78;AF=0.42;MQM=58	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6576+1194G>C:	SVA_C	rs138382676	0.0557	0.0000	0/0/0	0.0310							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	28					LRRK2 (inh=AD pLI=0.00)
chr12	40746849	40746849	C	T	hom		QUAL=497;DP=20;AF=0.95;MQM=55	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1252C>T:	SVA_C	rs10878411	0.6891	0.0000	0/0/0	0.1680							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				251	142					LRRK2 (inh=AD pLI=0.00)
chr12	40746867	40746867	C	T	hom	low_DP	QUAL=428;DP=18;AF=0.94;MQM=54	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1234C>T:	SVA_C	rs11176160	0.7019	0.0000	0/0/0	0.1728							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				302	174					LRRK2 (inh=AD pLI=0.00)
chr12	40746882	40746882	G	A	hom	low_DP	QUAL=323;DP=13;AF=1.00;MQM=52	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1219G>A:	SVA_C	rs11176161	0.7021	0.0000	0/0/0	0.1756							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				319	198					LRRK2 (inh=AD pLI=0.00)
chr12	40746913	40746913	T	C	hom	low_DP	QUAL=312;DP=12;AF=1.00;MQM=53	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1188T>C:	SVA_C	rs10878412	0.7023	0.0000	0/0/0	0.2154							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				327	187					LRRK2 (inh=AD pLI=0.00)
chr12	40746960	40746960	T	C	hom	low_DP;low_MQM	QUAL=219;DP=10;AF=0.90;MQM=49	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1141T>C:	SVA_C	rs10878413	0.7035	0.0000	0/0/0	0.1948							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				304	123					LRRK2 (inh=AD pLI=0.00)
chr12	40746993	40746993	C	T	het	low_DP;low_MQM	QUAL=50;DP=7;AF=0.71;MQM=47	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1108C>T:	SVA_C	rs189538849	0.0000	0.0000	0/0/0	0.0064							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				4	11					LRRK2 (inh=AD pLI=0.00)
chr12	40747019	40747019	C	T	hom	low_DP;low_MQM	QUAL=152;DP=7;AF=0.86;MQM=49	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1082C>T:	SVA_C	rs11610569	0.0000	0.0000	0/0/0	0.0374							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				124	30					LRRK2 (inh=AD pLI=0.00)
chr12	40747028	40747028	C	T	hom	low_DP;low_MQM	QUAL=109;DP=6;AF=1.00;MQM=47	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1073C>T:	SVA_C	rs142726158	0.6963	0.0000	0/0/0	0.1667							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				132	44					LRRK2 (inh=AD pLI=0.00)
chr12	40747045	40747045	A	G	hom	low_DP;low_MQM	QUAL=97;DP=5;AF=1.00;MQM=47	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1056A>G:	SVA_C	rs576444406	0.6933	0.0000	0/0/0	0.1322							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				115	19					LRRK2 (inh=AD pLI=0.00)
chr12	40747046	40747046	A	G	hom	low_DP;low_MQM	QUAL=97;DP=5;AF=1.00;MQM=47	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1055A>G:	SVA_C	rs185723137	0.6955	0.0000	0/0/0	0.1644							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				110	18					LRRK2 (inh=AD pLI=0.00)
chr12	40747059	40747059	C	T	het	low_DP;low_MQM	QUAL=55;DP=11;AF=0.55;MQM=35	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1042C>T:	SVA_C	rs189800607	0.0000	0.0000	0/0/0	0.0088							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				1	7					LRRK2 (inh=AD pLI=0.00)
chr12	40747068	40747068	C	T	het	low_DP;low_MQM	QUAL=86;DP=10;AF=0.70;MQM=38	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1033C>T:	SVA_C	rs71449759	0.0000	0.0000	0/0/0	0.0175							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	8					LRRK2 (inh=AD pLI=0.00)
chr12	40747074	40747074	G	A	het	low_DP;low_MQM	QUAL=160;DP=11;AF=0.82;MQM=41	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1027G>A:	SVA_C	rs186253816	0.0000	0.0000	0/0/0	0.0212							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	12					LRRK2 (inh=AD pLI=0.00)
chr12	40747081	40747081	G	A	hom	low_DP;low_MQM	QUAL=266;DP=12;AF=1.00;MQM=43	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1020G>A:	SVA_C	rs61915611	0.6921	0.0000	0/0/0	0.1625							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				53	8					LRRK2 (inh=AD pLI=0.00)
chr12	40747085	40747085	A	G	hom	low_DP;low_MQM	QUAL=266;DP=12;AF=1.00;MQM=43	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1016A>G:	SVA_C	rs61915612	0.6921	0.0000	0/0/0	0.1632							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				108	14					LRRK2 (inh=AD pLI=0.00)
chr12	40747091	40747091	A	G	hom	low_DP;low_MQM	QUAL=298;DP=16;AF=1.00;MQM=39	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-1010A>G:	SVA_C	rs61915613	0.0000	0.0000	0/0/0	0.0379							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				238	55					LRRK2 (inh=AD pLI=0.00)
chr12	40747146	40747146	A	G	hom	low_MQM	QUAL=708;DP=27;AF=1.00;MQM=47	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-955A>G:	SVA_C	rs140722234	0.7041	0.0000	0/0/0	0.3258							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				335	197					LRRK2 (inh=AD pLI=0.00)
chr12	40747242	40747242	C	A	hom	low_DP	QUAL=461;DP=17;AF=0.94;MQM=52	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-859C>A:	SVA_C	rs113693842	0.7033	0.0000	0/0/0	0.2107							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				267	118					LRRK2 (inh=AD pLI=0.00)
chr12	40747318	40747318	G	-	hom	low_DP;low_MQM	QUAL=173;DP=9;AF=1.00;MQM=35	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-779delG:	SVA_C	rs34531686	0.6999	0.0000	0/0/0	0.4429							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				106	25					LRRK2 (inh=AD pLI=0.00)
chr12	40747534	40747534	G	C	hom		QUAL=1419;DP=53;AF=0.98;MQM=50	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-567G>C:	SVA_C	rs3930031	0.7031	0.0000	0/0/0	0.3871							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				336	213					LRRK2 (inh=AD pLI=0.00)
chr12	40747772	40747772	G	C	hom		QUAL=6470;DP=225;AF=1.00;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-329G>C:	SVA_C	rs5017705	0.7031	0.0000	0/0/0	0.4496							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				337	216					LRRK2 (inh=AD pLI=0.00)
chr12	40747929	40747929	C	T	hom		QUAL=17127;DP=520;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon44/50:c.6577-172C>T:		rs7308626	0.7031	0.0000	0/0/0	0.7794							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40748395	40748395	G	A	hom		QUAL=15453;DP=470;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6770+101G>A:		rs890575	0.7031	0.0000	0/0/0	0.1776							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	216					LRRK2 (inh=AD pLI=0.00)
chr12	40748547	40748547	A	G	hom		QUAL=12478;DP=384;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6770+253A>G:		rs10748040	0.7031	0.0000	0/0/0	0.5334							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40748638	40748651	AAAAAAAAATATAT	-	hom		QUAL=8738;DP=303;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6770+345_6770+358delAAAAAAAATATATA:	(AT)n	rs199872328;rs61230125	0.8622	0.0000	0/0/0	0.6313							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				353	200					LRRK2 (inh=AD pLI=0.00)
chr12	40748664	40748664	A	C	het		QUAL=4862;DP=361;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6770+370A>C:	(AT)n	rs11176165	0.2045	0.0000	0/0/0	0.1316							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				9	120					LRRK2 (inh=AD pLI=0.00)
chr12	40749150	40749150	G	A	het		QUAL=4662;DP=470;AF=0.40;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-767G>A:	MER67D	rs7976715	0.4846	0.0000	0/0/0	0.4542							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				239	278					LRRK2 (inh=AD pLI=0.00)
chr12	40749172	40749172	G	A	hom		QUAL=15737;DP=478;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-745G>A:	MER67D	rs7976724	0.7021	0.0000	0/0/0	0.4617							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40749197	40749197	A	G	hom		QUAL=15644;DP=501;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-720A>G:	MER67D	rs7963987	0.7027	0.0000	0/0/0	0.4701							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40749218	40749218	G	C	hom		QUAL=15652;DP=488;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-699G>C:	MER67D	rs2162472	0.7027	0.0000	0/0/0	0.4828							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	213					LRRK2 (inh=AD pLI=0.00)
chr12	40749333	40749333	T	C	het		QUAL=388;DP=187;AF=0.22;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-584T>C:	MER67D	rs192718598	0.0000	0.0000	0/0/0	0.0096							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	384					LRRK2 (inh=AD pLI=0.00)
chr12	40749337	40749337	T	C	het		QUAL=388;DP=187;AF=0.22;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-580T>C:	MER67D	rs866143339	0.0000	0.0000	0/0/0	0.0017							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	57					LRRK2 (inh=AD pLI=0.00)
chr12	40749345	40749345	-	C	het		QUAL=182;DP=121;AF=0.28;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-571dupC:	AluSq2	rs552326490	0.1671	0.0000	0/0/0	0.0531							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	34					LRRK2 (inh=AD pLI=0.00)
chr12	40749350	40749351	TT	-	het		QUAL=1054;DP=110;AF=0.54;MQM=59	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-555_6771-554delTT:	AluSq2	rs112905910	0.6997	0.0000	0/0/0	0.1351							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				104	249					LRRK2 (inh=AD pLI=0.00)
chr12	40749352	40749352	T	C	het		QUAL=1054;DP=110;AF=0.54;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon45/50:c.6771-565T>C:	AluSq2		0.0000	0.0000	0/0/0	0.0001							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	36					LRRK2 (inh=AD pLI=0.00)
chr12	40750296	40750296	A	-	hom		QUAL=6231;DP=205;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6843+314delA:		rs796224481	0.7033	0.0000	0/0/0	0.6731							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40750549	40750549	T	A	hom		QUAL=9360;DP=279;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6843+560T>A:		rs7306545	0.7033	0.0000	0/0/0	0.7687							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40750820	40750820	A	G	hom		QUAL=12144;DP=377;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6843+831A>G:	L1MA4A	rs7306684	0.6947	0.0000	0/0/0	0.7771							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40750966	40750966	C	T	het		QUAL=4146;DP=338;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6843+977C>T:	L1MA4A	rs112259589	0.0645	0.0000	0/0/0	0.0877							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	54					LRRK2 (inh=AD pLI=0.00)
chr12	40751166	40751167	TT	-	hom		QUAL=9677;DP=340;AF=0.95;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6843+1185_6843+1186delTT:	L1MA4A	rs398055494	0.7037	0.0000	0/0/0	0.5909							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				340	215					LRRK2 (inh=AD pLI=0.00)
chr12	40751894	40751894	-	T	het		QUAL=2329;DP=483;AF=0.29;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6844-1156dupT:	L1MA4A	rs758880647	0.0000	0.0000	0/0/0	0.0684							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				0	28					LRRK2 (inh=AD pLI=0.00)
chr12	40751979	40751979	T	C	hom		QUAL=12665;DP=402;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6844-1083T>C:	L1MA4A	rs10784528	0.8245	0.0000	0/0/0	0.8446							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				435	142					LRRK2 (inh=AD pLI=0.00)
chr12	40752538	40752538	T	-	hom		QUAL=9614;DP=332;AF=0.96;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6844-516delT:	L1MA4A	rs796949072	0.8245	0.0000	0/0/0	0.6254							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				435	143					LRRK2 (inh=AD pLI=0.00)
chr12	40752603	40752603	A	T	het		QUAL=4731;DP=348;AF=0.51;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6844-459A>T:	L1MA4A	rs10784532	0.2049	0.0000	0/0/0	0.2727							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				10	119					LRRK2 (inh=AD pLI=0.00)
chr12	40752821	40752823	TTG	-	hom		QUAL=12796;DP=405;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon46/50:c.6844-228_6844-226delTGT:	L1MA4A	rs145580704;rs72063715	0.7033	0.0000	0/0/0	0.7177							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40753044	40753044	-	T	het		QUAL=4918;DP=282;AF=0.73;MQM=60	LRRK2	splice_region&intron	LRRK2:NM_198578.3:splice_region&intron:LOW:exon46/50:c.6844-8dupT:		rs111612315;rs150964683;rs386376254;rs540121252	0.5923	0.6216	12198/8193/567	0.5626							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				481	797					LRRK2 (inh=AD pLI=0.00)
chr12	40753303	40753303	A	G	hom		QUAL=6249;DP=192;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+57A>G:		rs3789330	0.7033	0.0000	0/0/0	0.1545							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				727	347					LRRK2 (inh=AD pLI=0.00)
chr12	40753774	40753774	C	T	het		QUAL=4103;DP=301;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+528C>T:		rs11836288	0.0647	0.0000	0/0/0	0.0867							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	54					LRRK2 (inh=AD pLI=0.00)
chr12	40754412	40754412	A	G	hom		QUAL=12652;DP=381;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+1166A>G:	L2c	rs10784536	0.7035	0.0000	0/0/0	0.7809							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	215					LRRK2 (inh=AD pLI=0.00)
chr12	40754680	40754686	TGCCTAT	-	hom		QUAL=15949;DP=550;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+1435_7028+1441delGCCTATT:	L2c	rs11277474	0.7033	0.0000	0/0/0	0.6898							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40754697	40754697	G	A	hom		QUAL=17182;DP=541;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+1451G>A:		rs7971919	0.7035	0.0000	0/0/0	0.5298							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40754782	40754782	T	G	hom		QUAL=16950;DP=532;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+1536T>G:		rs7962116	0.7035	0.0000	0/0/0	0.7805							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40755045	40755048	TACA	-	hom		QUAL=5117;DP=173;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7028+1801_7028+1804delCATA:		rs10548450	0.7035	0.0000	0/0/0	0.7164							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	214					LRRK2 (inh=AD pLI=0.00)
chr12	40755416	40755416	G	A	hom		QUAL=7449;DP=230;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-1788G>A:		rs2896978	0.7037	0.0000	0/0/0	0.7797							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				339	216					LRRK2 (inh=AD pLI=0.00)
chr12	40755476	40755476	A	T	hom		QUAL=5862;DP=178;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-1728A>T:		rs2404836	0.7037	0.0000	0/0/0	0.7803							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				341	213					LRRK2 (inh=AD pLI=0.00)
chr12	40756207	40756207	T	C	het		QUAL=5499;DP=457;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-997T>C:		rs11176195	0.0667	0.0000	0/0/0	0.0886							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				3	55					LRRK2 (inh=AD pLI=0.00)
chr12	40756248	40756248	A	G	hom		QUAL=13010;DP=403;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-956A>G:		rs4767973	0.5541	0.0000	0/0/0	0.6080							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				258	267					LRRK2 (inh=AD pLI=0.00)
chr12	40756472	40756472	C	A	hom		QUAL=16729;DP=507;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-732C>A:	L2c	rs4768236	0.5495	0.0000	0/0/0	0.6054							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				257	266					LRRK2 (inh=AD pLI=0.00)
chr12	40756687	40756687	T	C	hom		QUAL=9293;DP=282;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-517T>C:		rs4768237	0.5515	0.0000	0/0/0	0.6037							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				254	267					LRRK2 (inh=AD pLI=0.00)
chr12	40757114	40757114	-	CATG	hom		QUAL=4920;DP=155;AF=0.98;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon47/50:c.7029-87_7029-86insGCAT:		rs71653644	0.8273	0.0000	0/0/0	0.7667							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				328	245					LRRK2 (inh=AD pLI=0.00)
chr12	40757187	40757187	T	-	hom		QUAL=5263;DP=173;AF=0.98;MQM=60	LRRK2	splice_region&intron	LRRK2:NM_198578.3:splice_region&intron:LOW:exon47/50:c.7029-9delT:		rs397897325	0.5513	0.6319	23126/14322/1364	0.5553							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				574	607					LRRK2 (inh=AD pLI=0.00)
chr12	40757330	40757330	A	G	het		QUAL=2441;DP=193;AF=0.50;MQM=60	LRRK2	synonymous	LRRK2:NM_198578.3:synonymous:LOW:exon48/51:c.7155A>G:p.Gly2385Gly		rs33962975	0.0559	0.1129	1045/768/9	0.1102							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032509.2 [other]; 			30	386					LRRK2 (inh=AD pLI=0.00)
chr12	40757533	40757533	A	G	hom		QUAL=5390;DP=166;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon48/50:c.7181+177A>G:		rs7134408	0.5509	0.0000	0/0/0	0.6026							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				254	266					LRRK2 (inh=AD pLI=0.00)
chr12	40758045	40758045	T	G	het		QUAL=2047;DP=187;AF=0.42;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon48/50:c.7182-599T>G:		rs11835105	0.1867	0.0000	0/0/0	0.1994							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				38	241					LRRK2 (inh=AD pLI=0.00)
chr12	40758652	40758652	T	C	hom		QUAL=13513;DP=414;AF=1.00;MQM=60	LRRK2	missense	LRRK2:NM_198578.3:missense:MODERATE:exon49/51:c.7190T>C:p.Met2397Thr		rs3761863	0.5517	0.6240	23258/14344/1386	0.6097	0.3770	T	T	B	T	0.01	609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000032513.1 [uncertain significance]; RCV000375193.1 [benign]; 	CM1413562 [CLASS=DP MUT=ALT PHEN="Multiple system atrophy reduced risk" GENE=LRRK2]; 	COSM3753219, COSM3753218	1015	1044					LRRK2 (inh=AD pLI=0.00)
chr12	40759347	40759347	-	T	het		QUAL=1776;DP=166;AF=0.46;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon49/50:c.7390+500dupT:		rs869071120	0.4856	0.0000	0/0/0	0.4323							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				240	297					LRRK2 (inh=AD pLI=0.00)
chr12	40759848	40759848	T	A	hom		QUAL=11963;DP=360;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon49/50:c.7391-960T>A:		rs12426362	0.5513	0.0000	0/0/0	0.6052							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				265	285					LRRK2 (inh=AD pLI=0.00)
chr12	40759980	40759980	A	G	hom		QUAL=9554;DP=302;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon49/50:c.7391-828A>G:	L2b	rs17466605	0.5513	0.0000	0/0/0	0.6051							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				266	284					LRRK2 (inh=AD pLI=0.00)
chr12	40761007	40761007	A	G	hom		QUAL=5180;DP=161;AF=0.99;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon50/50:c.7462+128A>G:		rs3789328	0.5417	0.0000	0/0/0	0.5872							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				263	284					LRRK2 (inh=AD pLI=0.00)
chr12	40761315	40761315	A	T	het		QUAL=1561;DP=126;AF=0.50;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon50/50:c.7463-131A>T:		rs12426498	0.0643	0.0000	0/0/0	0.0152							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				2	55					LRRK2 (inh=AD pLI=0.00)
chr12	40761358	40761358	A	G	hom		QUAL=6739;DP=216;AF=1.00;MQM=60	LRRK2	intron	LRRK2:NM_198578.3:intron:MODIFIER:exon50/50:c.7463-88A>G:		rs4768238	0.8089	0.0000	0/0/0	0.1577							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];				469	147					LRRK2 (inh=AD pLI=0.00)
chr12	40761931	40761931	A	C	hom		QUAL=5483;DP=170;AF=0.99;MQM=60	LRRK2	3'UTR	LRRK2:NM_198578.3:3'UTR:MODIFIER:exon51/51:c.*364A>C:		rs10878441	0.5513	0.0000	0/0/0	0.1011							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000399691.1 [benign]; 			302	316					LRRK2 (inh=AD pLI=0.00)
chr12	40761951	40761951	C	T	hom		QUAL=5459;DP=164;AF=0.99;MQM=60	LRRK2	3'UTR	LRRK2:NM_198578.3:3'UTR:MODIFIER:exon51/51:c.*384C>T:		rs3886747	0.5515	0.0000	0/0/0	0.1015							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000306629.1 [benign]; 			303	316					LRRK2 (inh=AD pLI=0.00)
chr12	40762303	40762303	G	C	hom		QUAL=5450;DP=166;AF=1.00;MQM=60	LRRK2	3'UTR	LRRK2:NM_198578.3:3'UTR:MODIFIER:exon51/51:c.*736G>C:		rs1365770	0.5513	0.0000	0/0/0	0.1026							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000262903.1 [benign]; 			305	315					LRRK2 (inh=AD pLI=0.00)
chr12	40762546	40762546	T	C	hom		QUAL=8199;DP=264;AF=1.00;MQM=60	LRRK2	3'UTR	LRRK2:NM_198578.3:3'UTR:MODIFIER:exon51/51:c.*979T>C:		rs10784548	0.5513	0.0000	0/0/0	0.1027							609007 [LRRK2 (confirmed) Parkinson disease 8,607060];	RCV000265301.1 [benign]; 			303	317					LRRK2 (inh=AD pLI=0.00)
chr12	40763607	40763607	C	T	hom		QUAL=9423;DP=281;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40763607C>T:		rs1465527	0.8089	0.0000	0/0/0	0.8383											435	139					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40763616	40763616	C	T	hom		QUAL=9164;DP=276;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40763616C>T:		rs1465528	0.5485	0.0000	0/0/0	0.6007											254	267					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40763973	40763973	C	G	hom		QUAL=6947;DP=221;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40763973C>G:		rs7968048	0.5515	0.0000	0/0/0	0.6050											255	264					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40765586	40765589	AAAA	-	hom		QUAL=1643;DP=160;AF=0.56;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40765586_40765589delAAAA:	(A)n	rs149833872;rs574345039;rs778354262	0.0000	0.0000	0/0/0	0.2280											228	159					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40765603	40765603	A	C	hom		QUAL=1643;DP=160;AF=0.56;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40765603A>C:	(A)n	rs4374003	0.4627	0.0000	0/0/0	0.1578											269	238					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40765929	40765929	A	G	hom		QUAL=9733;DP=293;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40765929A>G:		rs7962370	0.8253	0.0000	0/0/0	0.8415											434	139					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40766252	40766252	T	C	het		QUAL=4991;DP=405;AF=0.49;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40766252T>C:		rs11176261	0.0643	0.0000	0/0/0	0.0870											2	52					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40766600	40766600	C	T	hom		QUAL=12311;DP=381;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40766600C>T:		rs10878452	0.0671	0.0000	0/0/0	0.0887											2	52					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40766722	40766722	-	TGAG	hom		QUAL=7385;DP=248;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40766722_40766723insTGAG:		rs10686038;rs71281664	0.7951	0.0000	0/0/0	0.7393											423	149					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40766904	40766904	C	G	hom		QUAL=5969;DP=184;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40766904C>G:		rs10467146	0.5443	0.0000	0/0/0	0.6012											253	266					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40767112	40767112	C	T	het		QUAL=1585;DP=130;AF=0.47;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40767112C>T:		rs17444306	0.0557	0.0000	0/0/0	0.0979											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40767990	40767990	G	C	hom		QUAL=12026;DP=389;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40767990G>C:	MamTip3B	rs4113953	0.5443	0.0000	0/0/0	0.4379											254	266					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40767992	40767992	T	C	hom		QUAL=12026;DP=389;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40767992T>C:	MamTip3B	rs5010412	0.5445	0.0000	0/0/0	0.4378											254	266					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40768582	40768582	G	A	het		QUAL=2813;DP=244;AF=0.44;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40768582G>A:	L1MC	rs4768239	0.0549	0.0000	0/0/0	0.0978											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769062	40769062	A	T	hom		QUAL=13262;DP=398;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769062A>T:	Tigger3b	rs1444221	0.5351	0.0000	0/0/0	0.5991											251	267					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769531	40769531	-	G	hom		QUAL=2958;DP=102;AF=0.98;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769531_40769532insG:	AluSz	rs111408652	0.2147	0.0000	0/0/0	0.2370											41	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769621	40769621	C	T	het		QUAL=733;DP=42;AF=0.86;MQM=56	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769621C>T:	Tigger3b	rs11836100	0.0000	0.0000	0/0/0	0.0064											4	212					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769658	40769658	-	GCTTCATT	hom		QUAL=2993;DP=120;AF=0.94;MQM=59	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769658_40769659insGCTTCATT:	Tigger3b	rs375559231	0.2139	0.0000	0/0/0	0.0705											41	232					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769718	40769718	-	TA	het		QUAL=590;DP=119;AF=0.30;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769718_40769719insTA:	Tigger3b	rs71078241;rs747387810	0.3063	0.0000	0/0/0	0.2001											1	161					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769918	40769918	G	A	hom		QUAL=6305;DP=192;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769918G>A:	Tigger3b	rs11176303	0.2145	0.0000	0/0/0	0.2504											41	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40769947	40769947	-	A	hom		QUAL=5222;DP=165;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40769947_40769948insA:	Tigger3b	rs112763378	0.2147	0.0000	0/0/0	0.2023											41	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40770342	40770342	G	A	hom		QUAL=13523;DP=419;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40770342G>A:	AluJb	rs3922212	0.2149	0.0000	0/0/0	0.2650											42	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40771193	40771193	T	A	het		QUAL=3301;DP=264;AF=0.48;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40771193T>A:		rs73107141	0.0551	0.0000	0/0/0	0.0923											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40771420	40771420	G	T	hom		QUAL=6442;DP=193;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40771420G>T:	L1ME3B	rs11176314	0.2147	0.0000	0/0/0	0.2408											41	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40772342	40772342	G	T	het		QUAL=3709;DP=279;AF=0.48;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40772342G>T:		rs17466724	0.0559	0.0000	0/0/0	0.0955											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40772543	40772543	G	A	het		QUAL=2909;DP=238;AF=0.47;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40772543G>A:	L2	rs11176330	0.1585	0.0000	0/0/0	0.1776											36	243					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40772807	40772807	G	A	het		QUAL=5490;DP=448;AF=0.50;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40772807G>A:	MLT1B	rs11176333	0.0635	0.0000	0/0/0	0.0859											2	52					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40772927	40772927	T	C	het		QUAL=5340;DP=426;AF=0.48;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40772927T>C:	MLT1B	rs17466745	0.0559	0.0000	0/0/0	0.0982											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40773282	40773282	C	T	hom		QUAL=10860;DP=344;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40773282C>T:		rs7955042	0.8103	0.0000	0/0/0	0.8405											383	179					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40773776	40773776	C	T	hom		QUAL=4165;DP=129;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40773776C>T:		rs11176341	0.2145	0.0000	0/0/0	0.2772											42	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40773804	40773804	T	A	het		QUAL=967;DP=77;AF=0.49;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40773804T>A:		rs73107145	0.0559	0.0000	0/0/0	0.0970											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40773852	40773852	A	G	het		QUAL=799;DP=70;AF=0.47;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40773852A>G:	(ATTATTT)n	rs73107146	0.0559	0.0000	0/0/0	0.0974											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40773875	40773875	T	C	het		QUAL=855;DP=62;AF=0.53;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40773875T>C:	(ATTATTT)n	rs11176342	0.0637	0.0000	0/0/0	0.0705											2	52					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40774168	40774168	G	A	het		QUAL=658;DP=54;AF=0.48;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40774168G>A:	L1PA10	rs11176346	0.0637	0.0000	0/0/0	0.0850											2	52					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40774423	40774423	-	AAG	hom		QUAL=4710;DP=146;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40774423_40774424insAAG:		rs10668566;rs35495233	0.7949	0.0000	0/0/0	0.7552											427	146					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40774519	40774519	T	C	het		QUAL=1437;DP=132;AF=0.43;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40774519T>C:		rs4768241	0.0559	0.0000	0/0/0	0.0973											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40774662	40774662	G	C	het		QUAL=1609;DP=148;AF=0.43;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40774662G>C:		rs4768242	0.0551	0.0000	0/0/0	0.0956											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40775244	40775244	T	C	het		QUAL=550;DP=65;AF=0.42;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40775244T>C:		rs73107147	0.0551	0.0000	0/0/0	0.0977											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40775279	40775279	-	T	hom		QUAL=1016;DP=49;AF=0.76;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40775279_40775280insT:		rs398116361	0.5809	0.0000	0/0/0	0.4724											119	423					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40775736	40775736	A	G	het		QUAL=5136;DP=419;AF=0.47;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40775736A>G:	L2a	rs17444368	0.0559	0.0000	0/0/0	0.0979											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40776221	40776221	G	C	hom		QUAL=9695;DP=304;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40776221G>C:	PABL_A	rs11176362	0.2137	0.0000	0/0/0	0.2784											41	263					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40776460	40776460	C	T	het		QUAL=5446;DP=384;AF=0.52;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40776460C>T:	PABL_A	rs73107149	0.0539	0.0000	0/0/0	0.0972											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40776874	40776874	T	C	hom		QUAL=1343;DP=50;AF=0.98;MQM=58	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40776874T>C:	AluSc8	rs4768243	0.8393	0.0000	0/0/0	0.7836											421	140					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40776910	40776911	AA	-	het		QUAL=244;DP=42;AF=0.43;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40776910_40776911delAA:	AluSc8	rs776881728	0.0000	0.0000	0/0/0	0.2416											11	68					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40776923	40776923	A	G	het		QUAL=244;DP=42;AF=0.43;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40776923A>G:	AluSc8	rs4768244	0.0555	0.0000	0/0/0	0.0262											3	26					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40777247	40777247	G	A	hom		QUAL=20996;DP=633;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40777247G>A:	L2a	rs4768245	0.2258	0.0000	0/0/0	0.2830											42	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40777316	40777316	T	G	hom		QUAL=14308;DP=444;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40777316T>G:	THE1C	rs12423567	0.2167	0.0000	0/0/0	0.2800											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40777697	40777697	T	C	hom		QUAL=13185;DP=436;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40777697T>C:	LTR17	rs11831981	0.2167	0.0000	0/0/0	0.2799											43	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40777742	40777742	A	G	het		QUAL=5095;DP=419;AF=0.46;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40777742A>G:	LTR17	rs17466781	0.0567	0.0000	0/0/0	0.0986											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40778002	40778002	T	C	hom		QUAL=10749;DP=341;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40778002T>C:	LTR17	rs2114570	0.6034	0.0000	0/0/0	0.6492											347	202					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40778691	40778691	G	T	hom		QUAL=12585;DP=391;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40778691G>T:	HERV17-int	rs11176375	0.2167	0.0000	0/0/0	0.2805											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40778957	40778957	C	A	hom		QUAL=13597;DP=426;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40778957C>A:	HERV17-int	rs10878496	0.2167	0.0000	0/0/0	0.2785											43	259					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40779003	40779003	T	G	hom		QUAL=13509;DP=440;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40779003T>G:	HERV17-int	rs10784575	0.2167	0.0000	0/0/0	0.2727											42	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40779073	40779073	C	T	hom		QUAL=23870;DP=752;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40779073C>T:	HERV17-int	rs7957611	0.9918	0.0000	0/0/0	0.8956											594	0					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40779292	40779292	C	A	hom		QUAL=21018;DP=643;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40779292C>A:	HERV17-int	rs7957905	0.9918	0.0000	0/0/0	0.8926											594	0					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40779611	40779611	C	G	hom		QUAL=11039;DP=339;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40779611C>G:	HERV17-int	rs1966787	0.2167	0.0000	0/0/0	0.2682											42	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40779716	40779716	T	C	hom		QUAL=10709;DP=327;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40779716T>C:	HERV17-int	rs1966788	0.2167	0.0000	0/0/0	0.2799											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780164	40780164	T	C	hom		QUAL=17153;DP=534;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780164T>C:	HERV17-int	rs10784576	0.2167	0.0000	0/0/0	0.2794											42	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780270	40780270	G	A	het		QUAL=6525;DP=527;AF=0.49;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780270G>A:	HERV17-int	rs2098963	0.1605	0.0000	0/0/0	0.1800											37	243					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780304	40780304	T	A	hom		QUAL=14797;DP=462;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780304T>A:	HERV17-int	rs2098964	0.2167	0.0000	0/0/0	0.2793											42	262					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780360	40780360	C	G	hom		QUAL=13750;DP=427;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780360C>G:	HERV17-int	rs2081702	0.8021	0.0000	0/0/0	0.7713											428	144					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780396	40780396	C	T	het		QUAL=4410;DP=322;AF=0.52;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780396C>T:	HERV17-int	rs149979405	0.0150	0.0000	0/0/0	0.0302											0	9					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40780701	40780701	C	A	het		QUAL=4508;DP=441;AF=0.44;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40780701C>A:	HERV17-int	rs11831092	0.1599	0.0000	0/0/0	0.1781											38	241					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781021	40781021	G	C	het		QUAL=6183;DP=456;AF=0.52;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781021G>C:	HERV17-int	rs148704728	0.0533	0.0000	0/0/0	0.0972											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781083	40781083	C	A	hom		QUAL=12137;DP=378;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781083C>A:	HERV17-int	rs1834744	0.2169	0.0000	0/0/0	0.2788											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781263	40781263	A	G	hom		QUAL=14910;DP=464;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781263A>G:	HERV17-int	rs1834745	0.8283	0.0000	0/0/0	0.8366											428	144					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781584	40781584	C	T	het		QUAL=5029;DP=365;AF=0.53;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781584C>T:	HERV17-int	rs2896981	0.0533	0.0000	0/0/0	0.0962											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781658	40781658	T	C	hom		QUAL=11044;DP=345;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781658T>C:	HERV17-int	rs2404839	0.2167	0.0000	0/0/0	0.2803											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40781819	40781819	T	A	hom		QUAL=12517;DP=413;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40781819T>A:	HERV17-int	rs1834746	0.8377	0.0000	0/0/0	0.8435											430	143					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40782046	40782046	C	T	het		QUAL=4457;DP=388;AF=0.45;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40782046C>T:	HERV17-int	rs17444481	0.0567	0.0000	0/0/0	0.0989											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40782721	40782721	G	A	het		QUAL=4063;DP=311;AF=0.49;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40782721G>A:	LTR17	rs17444494	0.0567	0.0000	0/0/0	0.0989											1	28					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40782903	40782903	G	A	hom		QUAL=9829;DP=317;AF=0.98;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40782903G>A:	LTR17	rs3906866	0.2167	0.0000	0/0/0	0.2806											43	260					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40783015	40783015	-	C	hom		QUAL=7508;DP=261;AF=0.97;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40783015_40783016insC:	LTR17	rs34084561;rs397780536	0.8033	0.0000	0/0/0	0.7517											412	160					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40783148	40783148	A	G	hom		QUAL=11515;DP=359;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40783148A>G:	LTR17	rs3906483	0.6048	0.0000	0/0/0	0.6501											347	201					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40783158	40783158	C	T	het		QUAL=3984;DP=369;AF=0.44;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40783158C>T:	LTR17	rs17466886	0.1536	0.0000	0/0/0	0.1924											30	229					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40783374	40783374	C	T	hom		QUAL=13205;DP=409;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40783374C>T:	THE1C	rs11176402	0.2159	0.0000	0/0/0	0.2799											43	261					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40784508	40784508	A	G	hom		QUAL=15436;DP=474;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40784508A>G:	L2a	rs12314982	0.6068	0.0000	0/0/0	0.6380											248	269					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40784662	40784662	T	C	hom		QUAL=9200;DP=281;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40784662T>C:	L2a	rs2081700	0.5913	0.0000	0/0/0	0.6244											247	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40784672	40784672	C	T	hom		QUAL=8743;DP=265;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40784672C>T:	L2a	rs2081701	0.5913	0.0000	0/0/0	0.5934											247	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40785508	40785508	C	T	hom		QUAL=7539;DP=230;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40785508C>T:		rs2896982	0.5909	0.0000	0/0/0	0.6218											246	268					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40785515	40785515	G	T	hom		QUAL=7162;DP=221;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40785515G>T:		rs4351885	0.5911	0.0000	0/0/0	0.5155											246	268					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40785533	40785533	T	C	hom		QUAL=8114;DP=255;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40785533T>C:		rs4280068	0.5919	0.0000	0/0/0	0.6219											246	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786102	40786102	G	A	hom		QUAL=8956;DP=278;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786102G>A:		rs7135650	0.5929	0.0000	0/0/0	0.4387											246	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786103	40786103	T	C	hom		QUAL=8956;DP=278;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786103T>C:		rs7310390	0.5929	0.0000	0/0/0	0.4402											246	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786215	40786215	T	C	hom		QUAL=9604;DP=299;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786215T>C:		rs7975124	0.5917	0.0000	0/0/0	0.6232											248	269					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786497	40786497	G	A	het		QUAL=5416;DP=426;AF=0.49;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786497G>A:		rs28365238	0.0703	0.0000	0/0/0	0.0880											3	50					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786719	40786719	A	G	hom		QUAL=4281;DP=142;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786719A>G:		rs7954300	0.5917	0.0000	0/0/0	0.6130											247	269					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786765	40786765	A	G	hom		QUAL=5954;DP=192;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786765A>G:		rs7954318	0.5925	0.0000	0/0/0	0.6243											247	270					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786804	40786804	T	C	hom		QUAL=6386;DP=197;AF=0.99;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786804T>C:		rs10784585	0.6526	0.0000	0/0/0	0.6703											343	205					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40786987	40786987	A	G	hom		QUAL=21232;DP=665;AF=1.00;MQM=60	LRRK2-MUC19	intergenic_region	LRRK2-MUC19:LRRK2-MUC19:intergenic_region:MODIFIER::n.40786987A>G:		rs1427259	0.8325	0.0000	0/0/0	0.8512											439	140					LRRK2-MUC19 (inh=n/a pLI=n/a)
chr12	40787385	40787385	C	A	hom	gene_blacklist	QUAL=8477;DP=253;AF=1.00;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+84C>A:		rs7968721	0.5899	0.0000	0/0/0	0.6236											249	268					MUC19 (inh=n/a pLI=n/a)
chr12	40787679	40787679	G	C	hom	gene_blacklist	QUAL=8437;DP=260;AF=1.00;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+378G>C:	Tigger1	rs11176421	0.6450	0.0000	0/0/0	0.6633											343	205					MUC19 (inh=n/a pLI=n/a)
chr12	40787742	40787742	C	G	hom	gene_blacklist	QUAL=13708;DP=425;AF=0.99;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+441C>G:	Tigger1	rs12423950	0.1713	0.0000	0/0/0	0.2019											4	80					MUC19 (inh=n/a pLI=n/a)
chr12	40787808	40787808	G	T	het	gene_blacklist	QUAL=5184;DP=435;AF=0.47;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+507G>T:	Tigger1	rs12426513	0.0711	0.0000	0/0/0	0.0891											3	50					MUC19 (inh=n/a pLI=n/a)
chr12	40788379	40788379	C	T	het	gene_blacklist	QUAL=5052;DP=412;AF=0.46;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+1078C>T:	Tigger1	rs10878507	0.4784	0.0000	0/0/0	0.4461											153	295					MUC19 (inh=n/a pLI=n/a)
chr12	40789318	40789318	A	G	hom	gene_blacklist	QUAL=12292;DP=383;AF=0.99;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+2017A>G:	Tigger1	rs1822606	0.8323	0.0000	0/0/0	0.8507											439	140					MUC19 (inh=n/a pLI=n/a)
chr12	40789380	40789380	C	T	het	gene_blacklist	QUAL=4227;DP=305;AF=0.51;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+2079C>T:	Tigger1	rs3885053	0.1066	0.0000	0/0/0	0.0980											3	51					MUC19 (inh=n/a pLI=n/a)
chr12	40789410	40789410	T	C	hom	gene_blacklist	QUAL=9231;DP=297;AF=1.00;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.52+2109T>C:	Tigger1	rs7966143	0.8211	0.0000	0/0/0	0.8302											440	139					MUC19 (inh=n/a pLI=n/a)
chr12	40789571	40789571	G	C	het	gene_blacklist	QUAL=3542;DP=326;AF=0.43;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.53-2110G>C:	Tigger1	rs4768246	0.0539	0.0000	0/0/0	0.0969											1	30					MUC19 (inh=n/a pLI=n/a)
chr12	40789725	40789725	T	A	het	gene_blacklist	QUAL=4996;DP=368;AF=0.51;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.53-1956T>A:	Tigger1	rs2217148	0.7548	0.0000	0/0/0	0.7438											412	160					MUC19 (inh=n/a pLI=n/a)
chr12	40790363	40790363	A	G	het	gene_blacklist	QUAL=2573;DP=185;AF=0.52;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.53-1318A>G:		rs10784587	0.7548	0.0000	0/0/0	0.7409											413	160					MUC19 (inh=n/a pLI=n/a)
chr12	40790940	40790940	A	T	hom	gene_blacklist	QUAL=6171;DP=187;AF=0.99;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.53-741A>T:		rs1549562	0.8323	0.0000	0/0/0	0.8495											438	140					MUC19 (inh=n/a pLI=n/a)
chr12	40791214	40791214	T	C	het	gene_blacklist	QUAL=2732;DP=223;AF=0.46;MQM=60	MUC19	intron	MUC19:NM_173600.2:intron:MODIFIER:exon1/172:c.53-467T>C:	X12_DNA	rs10784589	0.4177	0.0000	0/0/0	0.3989											92	282					MUC19 (inh=n/a pLI=n/a)
